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A BST R A C T 
The present study investigated discrepancy between reports of depressive symptoms of 36 
psychogeriatric patients and their family informants. It also examined factors potentially 
affecting this discrepancy such as selected characteristics of the patients and their informants, 
the type of measure assessing depression, and the type of depressive symptoms being 
assessed. The 15-item Geriatric Depression Scale (GDS-15) and the Clinically Useful 
Depression Outcome Scale (CUDOS) were completed by the patient, and the informant 
version of both the GDS-15 and CUDOS were completed by their informant. A sizable 
discrepancy was found between patient and informant reports of depressive symptomatology; 
informants reported significantly more symptoms than patients themselves. The discrepancy 
in reports was greater on the GDS-15 than on the CUDOS. Multiple regression analyses 
????????? ????? ????? ?????????? ??????? ???? ????? ??? ???????? ??????????? ???? ???? ??????????
significantly influenced the discrepancy. The highest kappa agreement was obtained on items 
related to feelings of worthlessness and life satisfaction on the GDS-15, and suicidal ideation 
???? ??????? ??? ???? ??????? ???? ???????? ?????????? ???? ????????????? ????????????? ???? ?????????
practice and research, and directions for future research are discussed.  
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C H APT E R O N E 
1. Introduction 
 
     Depression is a common and debilitating mental-health problem amongst older people, but 
challenging to assess. Accurate diagnosis of depression is often complicated by multiple 
issues, such as coexisting physical and mental problems, cognitive difficulties, and changes 
resulting from normal ageing. The use of information from friends and family of the older 
person may be useful in increasing accuracy of depression recognition. However, there are a 
number of questions about differences between the reports of the individuals and their 
informants. Several variables, such as older person and informant characteristics, type of 
questionnaire used, and the type of depressive symptoms present can increase or decrease 
discrepancy between individual and informant reports of depressive symptomatology. The 
aims of the present study are to examine the discrepancy between ratings of depressive 
symptoms made by older people and their informants, and to investigate some of the factors 
that influence this discrepancy.  
 
1.1 Depression in Older People 
      According to the Diagnostic and Statistical Manual of Mental Disorders (DSM IV-TR; 
American Psychiatric Association, 2000), symptoms for Major Depressive Episode (MDE) 
include depressed or irritable mood; loss of interest or pleasure in usual activities; changes in 
appetite and weight; disturbed sleep; motor agitation or retardation; fatigue and loss of 
energy; feelings of worthlessness, self-reproach, or excessive guilt; suicidal thinking and 
attempts; and difficulty with thinking and concentration. Either depressed mood or loss of 
interest, accompanied by at least four additional symptoms of MDE, need to be present 
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during the same two-week period and represent a change from previous functioning 
(American Psychiatric Association, 2000). Major Depressive Disorder (MDD; referred to in 
the present study as depression) is characterized by one or more Major Depressive Episode 
without a history of Manic, Mixed, or Hypomanic Episodes (American Psychiatric 
Association, 2000). 
     The average age at onset of depression is in the mid-20s but it may begin at any age. At 
least 60% of individuals who have had a single depressive episode can be expected to have a 
second one. Individuals who have suffered from two episodes have a 70% chance of having a 
third one, and individuals who have had three episodes have a 90% chance of having a fourth 
(Mattisson, Bogren, Horstmann, Munk-Jorgensen, & Nettelbladt, 2007). Thus, in a 
substantial number of cases the depression is chronic and recurrent. Accordingly, it has been 
established that older adults who have experienced depression once are more likely to 
experience a recurrence of their illness (Reynolds, Frank, Dew, Houck, Miller, Mazumdar, et 
al., 1999). 
     The 12-month prevalence of depression among community dwelling older people has been 
estimated to range from 0.6% to 1.7% (Bruce & McAvay, 1998; Browne Oakley, Wells, & 
Scott, 2006).  The 12-month prevalence of subsyndromal depression (i.e., symptoms of 
depression that do not meet standard criteria for MDD) is around 25% (Lebowitz et al., 
1997). The prevalence of depression is higher in medical and institutional settings than for 
older people living in the community. The 12-month prevalence in primary care samples is 
6% to 8%, in nursing home samples ranges from 5% to 26%, in a sample of elderly home-
care patients is 13.5%, and in acutely hospitalized older patients is up to 28% (Bruce & 
McAvay, 1998; Bruce et al., 2002; Koenig, 1997; Li & Yeates, 2007; Seitz, Purandare, & 
Conn, 2010). Additionally, both the prevalence and incidence of depression double for people 
aged 70 ? 85 years (Nordhus, 2008).  
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     In late life there are some identified differences in the presentation of symptoms of 
depression (Blazer, 1994; Kane, Ouslander, & Abrass, 2004). These include a lower 
prevalence of dysphoria or depressive thoughts, fewer ideational symptoms (such as guilt or 
suicidal ideation) but more prominent and specific somatic symptoms (constipation, weight 
loss, and aches), feelings of anxiety, and cognitive dysfunction. Also feelings of decreased 
self-esteem and worthlessness are more frequently reported in the elderly, and ruminative 
thinking may be prominent (Lawrence, Davidoff, & Berlow, 2003). Hopelessness about 
future and thoughts about death may be more normative for older people and are not 
sufficient to indicate depression in the absence of other symptoms (Burns, Lawlor, & Craig, 
2004). Depression presenting primarily with physical symptoms, which has been termed as 
masked depression, is common in the geriatric population (Kane et al., 2004). It has been 
suggested that the frequency with which somatic complaints predominate in older depressed 
people suggests that an atypical presentation of depression should be considered among the 
differential diagnostic assessment of patients presenting only with physical symptoms that 
cannot be explained on the basis of a non-psychiatric illness (Lawrence et al., 2003).   
     There is evidence that geriatric depression of any severity often results in several 
debilitating effects such as negative impact on well-being, increased social and physical 
disability, and earlier institutionalisation (Beekman, Deeg, Braam, Smit, & Van Tilburg, 
1997; Dorenlot, Harboun, Bige, Herard, & Ankiri, 2005). Depression has also been 
repeatedly linked to excess non-suicide mortality; depressed older individuals, particularly 
men, have shown a mortality increase of 2-3 times that of general population comparison 
groups of the same age (Burvill, 1994). Subthreshold depression has been associated with 
significant functional impairments (Blazer, 2003), risk for future MDD (Chopra et al., 2005), 
and lack of hope for the future (Adams & Moon, 2009). Also, individuals with dementia who 
suffer from depression have more frequent hospitalizations, have medical diagnoses in 
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greater number and severity, receive more psychiatric medications, and have higher pain 
prevalence than individuals with dementia without a diagnosis of depression (Bartels, Horn, 
& Smout, 2003). A group of primary care studies in the United States has demonstrated 
significantly higher health care costs for elderly people diagnosed with depression or 
subsyndromal depression (Katon, Lin, Russo, & Unutzer, 2003; Unutzer et al., 1997). 
Livingston and colleagues (Livingstone, Thomas, Graham, Blizard, & Mann, 1990) examined 
the use of health and social services by community-dwelling older people and discovered that 
??????????????????????????????????????????????????????????????????????????????ose that were not, 
were more likely to have seen their general practitioner in the previous month (48% versus 
37%). They were also more likely to have been hospitalized (39% versus 24%), require a 
district nurse (18% versus 9%), a home help (30% versus 19%), and be more frequent users 
of local day centre facilities (21% versus 11%) (Livingston et al., 1990). Depressive 
symptoms have also been associated with a subsequent decline in physical functioning 
(Bruce, Seeman, Merrill, & Blazer, 1994). Moreover, suicide is common in the geriatric 
population; older white males have the highest rate of completed suicide ? up to six times that 
of the general population (Lebowitz et al., 1997). Depression has also been recognised as a 
risk factor for suicide in older adults (Bruce et al., 2004). It is for these reasons that accurate 
assessment, in order to provide informed treatment of depression in later life, is vital.  
 
1.2 Challenges in Assessment of Depression in the E lderly 
     The adequate and time-efficient assessment and diagnosis of depression in older people is 
becoming an increasingly important public health issue as the number of individuals aged 65 
and older progressively grows. By 2010, around 13% of New Zealand?? population will be 
aged 65 years and over and thereafter the proportion of older people in the population will 
rise significantly (to 22% by 2013 and 25% by 2051) (Coe, 2003).  
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     Assessment of depression in older adults is complex. Several factors may make depressive 
symptoms difficult to interpret. Firstly, changes due to ageing, as well as several common 
medical conditions, can lead to the physical appearance of depression, even if depression is 
not present (Kane et al., 2004). Also, nonspecific and specific physical symptoms may 
represent a variety of treatable medical illnesses as well as depression (Kane et al., 2004). For 
example changes in sleep, appetite, and energy can be hard to distinguish from those due to 
age, medical illness, or depression. A study by Klerman (1989) found that 75% of older 
adults in primary care had at least one chronic medical illness that mimicked or shared 
symptoms of depression. Further complicating the issue, depression often accompanies many 
medical conditions and can exacerbate symptoms of coexisting physical illness (Kane et al., 
2004; Lyness et al., 1996). Any medical condition associated with systemic involvement and 
metabolic disturbances can have profound effects on mental and affective functioning (Kane 
et al., 2004). The most common among these are fever, decreased cardiac output, 
dehydration, electrolyte disturbances, and hypoxia. Systemic diseases, especially 
malignancies and endocrine disorders, are reportedly associated with symptoms of 
depression. For example patients with cancer of the pancreas often present with depression 
accompanied by anorexia and back pain. Among the endocrine disorders, thyroid and 
parathyroid conditions are most commonly associated with depressive symptoms. Zabora et 
al. found a prevalence of 36.6% of depressive symptoms among pancreatic cancer patients 
(Zabora, Brintzenhofeszoc, Curbow, Hooker, & Piantadosi, 2001). Hypothyroidism often 
presents as psychomotor retardation and irritability, and in older patients may also manifest 
as withdrawal and depressed mood. Hyperparathyroidism, with attendant hypercalcemia, can 
mimic depression as it often presents as apathy, fatigue, bone pain, and constipation. 
Cardiovascular and nervous system diseases can precipitate symptoms of depression. It has 
been reported that the incidence rate of depression following a stroke within the same year is 
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37.8%, and 25% within the same year after a myocardial infraction (Aben et al., 2003). Brain 
damage, especially in the frontal lobes, such as tumour and subdural haematomas has also 
been associated with depression (e.g. Lamar, Charlton, Morris, & Marcus, 2010). Older 
??????? ????? ?????????? ????? ???????????? Disease (AD) and vascular dementia, may have 
prominent symptoms of depression. A review by Castilla-Puents and Habeych (2010) found 
an overall prevalence of depressive disorders among patients with dementia of 27.41%. 
????????? ????? ???????????? ???????? ????? ????? ?? ????? ?????????? ??? ???????????? ?????? ???????
across studies between 7 and 75% (Braam et al., 2010). Depression that develops in response 
to chronic pain, loss of function and self-esteem, dependence, and the fear of death that 
accompany physical illness can become severe (Kane et al., 2004). A glossary of some of the 
medical terms used in the introduction is included in Appendix A.  
     Cognitive impairment, more frequent among older than among younger adults, presents a 
further difficulty in the assessment of depressive symptoms (Lawrence et al., 2003). Poor 
recall, reduced insight, and age-related declines in working memory capacity may interfere in 
obtaining accurate reports about the presence, severity and duration of symptoms (Knauper & 
Wittchen, 1994). Moreover, it is also initially difficult to distinguish deficits in cognitive and 
behavioural functioning that are caused by mood disorders from those due to an early 
dementing disorder (Nordhus, 2008). It is common that depressed older people who present 
with cognitive dysfunction (such as impaired memory or concentration) often have dementia-
like symptoms without actually having dementia (Blazer, 1999). In these incidences, 
cognitive deficits are often ameliorated through antidepressant treatment (Zisook & Downs, 
1998). Nevertheless, a differential diagnosis can be complicated as recent evidence suggests 
that depression and cognitive decline in the elderly might be correlated. A study by Jorm 
(2001) reported that depression, especially late-onset depression, may be a risk factor in the 
development of dementia. Additionally, a long-term follow up study by Alexopoulos and 
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colleagues (Alexopoulos, Meyers, Young, Mattis, & Kakuma, 1993) concluded that 
depressive symptoms may be one of the earliest manifestations of primary degenerative 
dementia. There are no widely used guidelines that would guarantee a correct diagnosis of 
these two conditions (Fairchild & Scogin, 2008). However, several researchers have 
considered how to differentiate between depression and dementia, most note worthy being 
the observed differences in memory functioning, and more specifically in the rate of 
forgetting (Lamberty & Bieliauskas, 1993). Those with depression performed at or close to 
levels of non-depressed peers whereas those with early dementia performed more poorly. 
Also, individuals with dementia showed great difficulty in completing a task that required 
them to organise and learn new material while those with depression performed more poorly 
than normal subjects, but were able to use material presented to them in an organised manner. 
From a clinical perspective, it has been recommended that for patients presenting with both 
depressive symptoms and cognitive disturbances, the diagnosis of a depressive episode 
should be considered whenever anhedonia, an emphasis on personal failures, feelings of 
worthlessness, or suicidal ideation are present (Zisook & Downs, 1998). Furthermore, there 
have been recent suggestions in the treatment literature that depression in the elderly should 
be considered as both a mood and a cognitive disorder (Walker & Steffens, 2010). 
     In addition to experiencing more frequent physical health difficulties and cognitive 
deficits (relative to younger adults), older adults commonly face many adverse life losses: of 
jobs, money, homes, abilities, hopes, dreams, friends and family (Zisook & Downs, 1998). 
These losses can underlie fear, demoralization, or loneliness, and in some of the more 
vulnerable elderly they can contribute to the onset, worsening, or persistence of depression 
(Zisook & Downs, 1998). It has been shown that many older people as well as their family 
(and often clinicians) believe that depression is a normal response to those losses associated 
with aging (Katona, 2000; Unutzer, Katon, Sullivan, & Miranda, 1999). This misconception 
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exacerbates the problem of accurate assessment of depression in the elderly and subsequently 
interferes with effective treatment of this debilitating condition (Benek-Higgins, 
McReynolds, Hogan, & Savickas, 2008). 
     In summary, several challenges surround the assessment of depression in the elderly. 
Different depression-like symptoms can represent not only depression, but physical illness, or 
a combination of both. Cognitive deficits, if present, can affect the accuracy of self-reported 
presentation as well as overlap with diagnostic symptoms of depression. Misconceptions 
?????????????????????????????????????????????????????????????????????? add further difficulties 
in recognising depression in the elderly.  
 
1.3 Methods of Assessment of Depression in the E lder ly  
     When selecting methods of assessment for use with older people, the clinician is 
encouraged to consider the goals of the assessment, the length of time for assessment, the 
availability of other informants, the stamina of the older adults, and the availability of 
appropriate norms for the age, gender, education, and ethnicity of the patient (Edelstein, 
Northrop, & MacDonald, 2009). The use of multiple methods is recommended and there is a 
variety of methods to choose from, including structured or unstructured clinical interview, 
direct observation, self-report scales, and informant-report measures (Fairchild & Scogin, 
2008). All of these methods are used in research and clinical practice. However, only self- 
and informant-report scales are of relevance to the present study and thus the description 
below will focus only on them.  
1.3.1 Self-report.  
     Self-report scales are used commonly with older adults and are an important part of the 
assessment of depression. They are most commonly used as screening instruments and to 
determine the severity of depressive symptoms. They also allow monitoring of an 
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????????????? ????????? ????? ????? ???? comparisons with normative values from appropriate 
populations. Self-report depression scales are questionnaires that can either be read to or by 
the older person. They do so at a symptomatic level with a general assumption that there is a 
linear relationship between the scores and the severity of depression (Burns et al., 2004). 
Some of the disadvantages of using self-report measures are the requirements of good vision 
and adequate reading comprehension (Nordhus, 2008). Deficits in any of these functions can 
influence the validity and reliability of obtained information. Verbal administration of self-
report inventories can to some extent compensate for sensory and/or some of the cognitive 
deficits (Edelstein et al., 2009). However, the evidence for utility of self-reported depression 
questionnaires is mixed in regard to cognitively impaired older adults (Edelstein, Kalish, 
Drozdick, & McKee, 1999). It has been reported in several studies that people with AD 
routinely underreport their symptoms of depressive symptomatology (e.g. Snow, Kunik, 
Molinari, Orengo, Doody, Graham et al., 2005). Efforts have been undertaken to determine 
the point at which self-reports of individuals with AD are no longer considered valid 
(Perkins, 2007). It has been found that self-??????????????????????????????????????????? the 
Mini Mental Status Examination (MMSE) were considered to be valid; however, below that 
level dementia impairment is considered to be too severe to enable reliable self-expression 
(Logsdon, Gibbons, McCurry, & Teri, 2002). Another disadvantage of self-report measures 
for detecting depression is their tendency to overestimate presence of MDD in the elderly 
(Arean, Uncapher, & Satre, 1998). In addition, self-reported screening instruments for 
depression rarely cover all of the criteria needed for a diagnosis of depression (Edelstein, et 
al., 2009). Thus, it has been suggested that reliance on total scores, without qualitative 
appraisal of self-reported responses, can be misleading in a clinical context (Woods, 2008). 
The use of multiple assessment methods can compensate for some of the limitations of self-
report measures noted with elderly individuals.  
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     Whether supported by objective results or not, self-report can often reveal the older 
????????? ????????????????????????????? ??????? ??????????????????????? ????? ??????????? ????????
into a ???????? own interpretation of his or her condition (Edelstein et al., 2009).  
Importantly, self-report depression scales usually require little time and resources to 
administer and score. Thus, their use as a screening or outcome measure is often effective in 
primary and secondary care (e.g. Smalbrugge, Jongenelis, Pot, Beekman, & Eefsting, 2008; 
Watson & Pignone, 2003).  
1.3.2 Use of informants. 
     Several authors recommend the involvement of multiple informants in the assessment of 
mental health of older adults (e.g. Davison, McCabe, & Mellor, 2009; Edelstein et al., 2009; 
Woods, 2008). Considering the many difficulties associated with assessment of depression in 
the elderly, obtaining information from family members, caretakers, or other resource people 
can often be helpful.     
     The use of informants in assessing depression in the geriatric population can be beneficial 
for a variety of reasons. A study conducted by McAvy, Bruce, Raue and Brown (2004) found 
that obtaining informant reports of depression may be a useful method for detecting clinically 
significant cases of geriatric depression that would otherwise be missed when relying only on 
patient report. As it was noted by Zisook and Downs (1998), the oldest age group (80 years 
and older) are especially prone to deny not only DSM-IV mood symptoms of depression, but 
also many of the standard symptoms such as poor sleep or appetite. Moreover, some of the 
depressive symptoms have been recognised to be more often identified by the family member 
or a caretaker than by the older person themselves or by their general practitioner (Burrows, 
Satlin, Salzman, Nobel, & Lipsitz, 1995; Davison et al., 2009). It has also been noted, that in 
clinical settings information obtained from a relative or carer may assist in the initial 
assessment of reluctant or inaccessible older patients (Lewis, Hinchcliffe, Katona, & 
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Livingstone, 1998). There are some suggestions that the use of informant-rated scales may 
assist in overcoming some of the problems inherent in the use of self-report measures with 
older people, such as visual acuity problems or cognitive impairment (Burke et al., 1998; 
Woods, 2008). In regard to assessment of depression in older people with dementia, several 
investigators have emphasized the importance of obtaining information from both the person 
with dementia and his/her informant. Family members were found to be often more aware 
than cognitively impaired individuals themselves of abnormal shifts in mood (Ballard, 
Bannister, & Oyebode, 1996). Rubin and colleagues concluded that family informants are 
essential in diagnosing clinically significant depressive symptoms in individuals with very 
mild to mild dementia of the Alzheimer type (Rubin, Veiel, Kinscherf, Morris, & Storand, 
2001). There is a general agreement in the clinical literature that as the severity of dementia 
increases, determination of depressive symptoms via self-report scales becomes less reliable 
and informant measures become necessary (e.g. Burns et al., 2004; Edelstein et al., 2009).   
     However, assessment information provided by informant, although very valuable, is often 
not without a bias and cannot be uncritically accepted. Personal characteristics of the 
informant, especially their own mental and physical health, ???????????????????????ge of the 
??????????????????????????????? the accuracy of their ratings. For example Rosenberg, Mielke, 
???? ????????? ??????? ????????? ???????????? ?????? ????? ??????????? ??? ??????????? ??? ???
individuals with AD. They found that caregiver depression and sense of burden affected their 
???????? ???????????????? ??????????? ???????????????? ??? ???? ????? ????? ?????? ????? ??? ?????????
with dementia one of the most commonly utilized informants is a spouse. However, often the 
spouse has significant cognitive, emotional, social, or physical problems that may influence 
accuracy in reporting (Burke et al., 1998). 
     Thus, the knowledge of rates of agreement/disagreement between geriatric patients and 
their informants as well as awareness of several factors that can influence discrepancies 
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between them can assist in accurate interpretation and informed use of data obtained from 
informants.  
 
1.4 Level of Agreement between O lder Person and Informant Reports of 
Depressive Symptomatology  
     A modest number of studies have examined level of agreement between older person and 
informant reports of depressive symptomatology.  Bassett, Magaziner, and Hebel (1990) 
examined the correspondence between 538 community-dwelling older women and their 
family informants? responses on Centre for Epidemiological Studies Depression Scale (CES-
D). The authors found a moderate correlation of .59 between respondent and informant 
responses. However, when examining informant bias, there were no significant differences 
between older women and their informants mean scores. Using the same instrument, 
Magaziner and colleagues (Magaziner, Zimmerman, Gruber-Baldini, Hebel, & Fox, 1997) 
compared responses of 233 medical outpatients with their family informants. They reported a 
moderate correlation of .45, fair kappa agreement of .38, and positive bias which suggested 
that informants were consistently overrating depressive symptoms. However, this bias was 
statistically significant only when the CES-D was scored as a continuous measure as opposed 
to dichotomous scoring.  In a sample of 355 elderly medical homecare patients, which used 
the mood section of the Structured Clinical Interview for DSM-IV (SCID), an overall 
observed agreement was 76% and kappa was .39 (McAvay et al., 2004). The authors also 
concluded that family informants tended to report more symptoms than the elderly patient; 
the overall prevalence of major depression was 9% according to both sources, but informants 
reported more subsyndromal depression than patients, 13% and 8% respectively. Teri and 
Wagner (1991) investigated the agreement between elderly outpatients with diagnosed AD 
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and their caregivers using the Hamilton Rating Scale for Depression (HAM-D). They 
reported a moderate to high correlation of .65 between patients and caregivers total scores on 
HAM-D, as well as an overall finding that caregivers reported more symptoms of depression 
than did patients.  A validation study of the 30 item collateral version of the Geriatric 
Depression Scale (CS-GDS-30), which compared self and informant reports of depressive 
symptoms, found that informants reported 28 of 30 items more frequently than patients, but 
the sensitivity of patient and informant total GDS-30 scores was nearly identical, .7 and .68 
respectively when different cut offs were used (14 and 21 respectively) (Nitcher, Bourke, 
Roccaforte, & Wengel, 1993). Similarly, a validation study of the CS-GDS-30 administered 
by telephone, reported that while family and friends reported the same pattern of depressive 
symptoms as the subject, they reported these symptoms at a higher rate (Burke, Rangwani, 
Roccaforte, Wengel, & Conely, 1997). Finally, Burke and colleagues (Burke et al., 1998) 
assessed depressive symptoms using the GDS-30 on a sample of 198 subjects with possible 
or probable AD and 64 cognitively intact subjects. They also found that, in general, family 
informants consistently perceived more depressive symptoms than subjects. 
     In summary, studies which investigated the agreement between target older person self-
reports and informant reports of depressive symptomatology, have found moderate 
correlations ranging from .45 to .65. Thus, there is some evidence supporting the validity of 
informant reports in assessment of depression in late life. At the same time, studies 
consistently find that there is a considerable discrepancy between older person and informant 
reports of depression. Furthermore, some of the studies found that informants have a 
tendency to report more depressive symptoms than the older individuals themselves.  
 
 
     
  
23 
1.5 Factors A ffecting Discrepancies between O lder Person and Informant 
Reports of Depressive Symptomatology  
     The finding that self-rated and informant-rated reports are never perfectly correlated is 
consistent across multiple constructs, patient populations, and types of raters (Snow, Cook, et 
al., 2005). Several variables have been found to influence the magnitude of these 
discrepancies. These include ????? ???? ?????????? ???? ???????????? ????????????????? ????
assessment method, and characteristics of the construct being assessed. Patients? 
demographic characteristics appear to be an important factor; for example, older individuals 
appear less likely to endorse psychiatric symptomatology than younger elderly individuals 
(e.g., McAvay et al., 2004). Ratings have also been found to be affected by the ????????????
overall level of education and by specific knowledge of the assessed construct (Neumann, 
Araki, & Gutterman, 2000). It has been noted that the more the assessment methods of 
patients and informants vary, the more discrepancy between their reports might be expected 
(Snow, Cook, et al., 2005). Finally, it has been found that the more subjective a construct is 
the larger the discrepancy between self- and informant ratings. Good agreement between self- 
and informant ratings has been reported for levels of functioning, overall health, less private 
chronic physical health conditions and symptoms (e.g. skin conditions), and preferences for 
type of health care setting (Neumann et al., 2000). Moderate agreement was reported for 
estimates of cognitive status, whereas moderate to low agreement has been found for 
depressive symptoms, psychological well-being, quality of life, and pain (Neumann et al., 
2000). 
     The factors that affect the magnitude of discrepancies between older individuals and 
his/her informant reports of depressive symptoms are not that well understood. A few studies 
examined the ???????????????????????????????????? ???????????????????????????????????????????????
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disability, and cognitive functioning; informa????? ???? ???? ????? ??? ????????????? ??? ???? ??????
person; a form of questionnaire used; or type of depressive symptoms present. These studies 
are discussed below in more detail.  
1.5.1 Patient characteristics. 
     The previously mentioned study by McAvay et al. (2004) examined associations between 
patterns of agreement/disagreement and patient and their family informant characteristics. 
They found that the ?????????? ???????? ???????????? ???? ??????????? ??? ?????? ??????? ????bility 
levels ???????????????????????????????????????????????????????????????????????????????????????
depression.  More specifically, patients with higher medical comorbidity and disability were 
more likely to underreport depressive symptoms. Using the same sample, McAvay, Raue, 
Brown, and Bruce (2005) found an overall trend that for patients with cognitive impairment, 
informants were more likely to report more psychological symptoms than they did for 
cognitively intact patients. This discrepancy was explained by the fact that cognitively intact 
patients were more likely to report suicidal thoughts or ideation as opposed to cognitively 
impaired patients who were less likely to report these symptoms. In both studies (McAvay et 
al., 2004; McAvay et al., 2005), there was a 40% refusal rate among sampled patients; those 
who refused to participate were more likely to be female, unmarried, living alone, and 
without children. Considering a high refusal rate, there is a possibility results were affected 
by non-participation bias. 
     Burke et al. (1998) implicated the role of insight in explaining the discrepancy in reporting 
depressive symptoms by older people with AD and their family informants. Participants with 
AD who had partial or no insight reported significantly fewer depressive symptoms than 
those who were cognitively intact. At the same time, those AD participants with full insight 
reported essentially the same number of symptoms as cognitively intact participants. Thus, 
lower level of insight increased the discrepancy between the older person and their informant 
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reports of depressive symptoms. This effect was observed for participants with AD but not 
for cognitively intact ones. One of the limitations of the Burke et al. (1998) study was that the 
insight variable was a post-hoc creation using three of the GDS items that relate to memory 
and concentration. By doing so a concept of insight was restricted to only awareness of 
cognitive deficits, which puts the generalizability of findings into question.  
     Cacchione et al. (2003) examined the reporting accuracy of family informants regarding 
cognitive capabilities of 515 individuals with very mild to mild AD (Cacchione, Powlishta, 
Grant, Buckles, & Morris, 2003). Characteristics of the elderly individuals with AD that 
related to greater accuracy of the informant were being male, younger, and more educated. 
Also, using a sample of male dementia patients Ross et al. (1997) found that older age and 
lower level of education were positively associated with inaccuracy of informant reports of 
older patients cognitive functioning. Although these studies did not examine the accuracy in 
reporting depressive symptomatology, they were carried out in a sample of elderly patients 
and some of the assessed symptoms overlapped with cognitive symptoms of depression (e.g., 
memory difficulties and concentration).  
     Overall, there are not many studies that have examined the role of specific older adults? 
characteristics in affecting the discrepancy between older person and informant reports of 
depressive symptomatology. There is some evidence in support of the conclusion that greater 
medical comorbidity and activities of daily living disability as well as decreased insight may 
increase discrepancy between older individual and informant reports of depression 
symptomatology. There is also, from studies assessing cognitive functioning, some support 
???? ????? ???????????? ???????? ??? ?????????? ?????? ???? ???? ????? gender widening the gap 
between older individual and informant reports.       
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1.5.2 Informant characteristics.  
      In the study by McAvay et al. (2005), younger informants, as compared to older ones, 
were found to have a significantly higher tendency to report more cognitive and 
psychological symptoms of depression than the patient. The authors concluded that the 
patterns of these discrepancies may in part reflect age- and cohort-related differences in 
concepts about normal cognitive and affective functioning. Similarly, Bassett et al. (1990) 
found that older informants reported fewer total depressive symptoms compared with 
younger informants. 
     The m???????????????????????????????????????????????????????????????????????????????????????
demographic ch???????????????????????????????????????????????????????????????? ????????????
gender and type of relationship to the older person affecting the agreement between the older 
person and informant reports of depression. Bassett et al. (1990) found that husbands 
significantly underestimated the presence of depressive symptomatology in comparison with 
the number of symptoms endorsed by their wives. Additionally, daughters provided less 
??????? ?????????? ??? ?????? ????????? ???????? ??? ??????????? ???????? than other types of 
informants. It is worth noting that the target sample used in the study comprised entirely of 
white women over the age of 65, who were generally healthy and lived in the urban 
community, thus generalizability of the findings might be limited and applicable only to 
similar samples.   
     In addition, Cacchione et al. (2003) found that spousal relationship, living with the 
individual with AD, and seeing the individual frequently increased the accuracy of 
???????????? ???????? Conversely, in a study by Burke et al. (1998) the relationship of the 
informant to the subject did not significantly affect discrepancy between their reports of 
depressive symptoms. 
     
  
27 
    On the whole, there is some sparse evidence implicating the ??????????????????????????????
factors that affect the discordant ratings of depression symptomatology. Specifically, the 
discrepancy in reports might be higher for male informants, and also for those who are 
younger. Studies that examined the ???????????? ????????????? ??? ???? ?????? ??????? ??ovide 
mixed results in terms of its role in having an effect on agreement between informant and 
older individual ratings of depression symptoms.  
1.5.3 Measure characteristics.  
     There is some suggestion in the literature that the type of questions used in questionnaires 
assessing symptoms of depression in the elderly and the consequent method used to score 
these questionnaires can influence response agreement and bias. Magaziner et al. (1997) 
observed less discordance between older person and informant reports of social functioning 
on questions which were relatively global and which asked simply about participation (i.e., 
dichotomous yes/no response options) than on questions asking about quantity of 
participation (i.e., continuous response options). Although, an overall agreement on reports of 
depressive symptoms was higher using the continuous response options, the use of 
impaired/unimpaired dichotomy was less likely to result in a biased estimate of impairment. 
???????? ???????????????????? ?????????? depressive symptoms were used as a gold standard, 
using a dichotomous response option resulted in less discrepancy between patient and 
informant ratings of depressive symptoms than when continuous response options were used.   
1.5.4 Type of presenting symptoms.  
     McDade-???????????????? ???????? ???? ???????? ??????? ????????? ???? ?????????? ??? ????
visibility effect on the ease of rating depression and anxiety symptoms by 53 family and 65 
staff (professional caregivers) informants of cognitively impaired patients. The visibility 
??????????????????????????more easily observed characteristics generally evidence greater 
agreement between raters?? ???????-Montez et al., 2008, p. 940). All participants were 
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given a version of the Inventory of Depression and Anxiety (IDAS), which consisted of 11 
standard symptom scales;174 items altogether. They were instructed to rate each item on a 4-
point scale ranging from 1 = very difficult to rate, to 4 = very easy to rate. The authors found 
that those symptoms of depression and anxiety that had more obvious external manifestations 
were easier for family and staff informants to rate, including appetite loss, lassitude, 
insomnia, and ill temper. Additionally, the more cognitive or emotional symptoms, such as 
suicidality and traumatic intrusions, were the most difficult for both family and staff members 
to rate. Appetite gain, social anxiety, well-being, and panic were intermediated in their 
ratability in both groups. There was a moderate correlation (.66) between the mean item 
ratability in two groups, suggesting that family members and staff members showed a strong 
level of agreement about which items were easier versus harder to rate. This supported the 
argument that certain types of depressive symptoms might be consistently easier to rate for 
informants, which in consequence would increase agreement between informant and patient 
ratings.  One of the limitations of the study is that the actual informant ratings and parallel 
patient ratings were not obtained so there was no actual comparison between these two 
sources of information.  
     McAvay et al. (2005) examined agreement between patient and informant reports 
according to type of depressive symptoms. In contrast to what they had hypothesised, 
observed agreement (51%) was poor and kappa agreement was only fair (.31) for somatic 
symptoms reports. Additionally, disagreements on the number of somatic symptoms did not 
follow a systematic pattern. A proposed reason for these unexpected results, was that 
differences in the type of individual somatic symptoms reported by patients and informants 
contributed to the overall disagreement. It was supported by the fact that patients were more 
likely to report sleeping problems, whereas informants were more likely to report fatigue. 
Observed agreement was higher (75%) and kappa agreement moderate (.41) for 
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psychological symptoms of depression. Also disagreements on psychological symptoms 
followed an asymmetric pattern; the probability of the informant reporting one more 
psychological symptom was 1.4 times that of the patient reporting an additional symptom and 
1.8 times reporting two symptoms. For cognitive symptoms observed agreement was also 
higher (82%), but kappa indicated only very slight agreement (.09). A pattern of 
disagreement was that informants were 1.7 times more likely to report an additional cognitive 
symptom than the patient. They hypothesised that the patients might not have been aware of 
symptoms such as indecisiveness, or ability to concentrate whereas informants were more 
likely to notice and report these symptoms. Finally, observed agreement was highest (90%) 
and kappa agreement was moderate (.41) for suicidal symptoms. The pattern of disagreement 
was reversed for suicidal items; patients were .52 times more likely to report them than 
???????????????? ???????? ?????????? ????? ????????? ????? ????? ???? ??? ???? ?????????? ???????????
reluctant to mention these types of thoughts to their children, spouses, or friends. 
     Teri and Wagner (1991) also found that certain depressive symptoms were more likely to 
be viewed differently among sources. For a depressed AD sample, patients endorsed 
significantly less often than family caregivers (mostly daughters and spouses) such symptoms 
as insomnia, change in interests, suicidal feelings, and somatic anxiety. Importantly, those 
four symptoms as well as initial insomnia and loss of insight, were found to best distinguish 
depressed from non-depressed patients in a discriminant function analysis using clinician 
ratings. Further understanding of the role of insight in the assessment of depression for 
people with dementia would be useful, but the implications for assessment with cognitively-
intact older people are not clear. 
     Davison et al. (2009) investigated the effect of including a staff informant interview on 
prevalence estimations of MDD in a sample of 168 residents of an aged-care facility. The 
results of an individual clinical interview for MDD were compared with those obtained when 
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a staff informant interview was incorporated into the assessment, and then both were 
compared with scores on the GDS-15. They identified a subsample of residents who, 
although recognised as depressed by the clinician and the informant, failed to disclose 
depressive symptoms in the clinical interview and endorsed a significantly lower number of 
items on the GDS-15. The symptom most commonly omitted in clinical interviews was 
depressed mood. Also other symptoms were commonly denied by those residents, including 
diminished interest or pleasure in activities, appetite disturbance or weight loss, lack of 
energy, worthlessness, and suicidal ideation. Thus, it is plausible to presume that agreement 
between older person and informant reports of the above depressive symptoms would be low. 
The authors suggested that the underreporting of these symptoms may reflect concern among 
older people about the stigma of mental illness, lack of insight into their mood, a tendency to 
normalize depressed mood, or reluctance to disclose affective symptoms. Noteworthy, the 
majority of the diagnostic interviews with older individuals and staff informants were 
conducted by a single clinician, thus the information obtained from both sources might not 
have been entirely independent. Also, the extent to which the study findings would apply to 
family informants is unclear.   
     In general, several studies have explored potential effects of the type of depressive 
symptoms present on agreement between older person and informant reports of depressive 
symptomatology. Symptoms with obvious behavioural manifestations have been found to be 
easier to rate for informants, which could subsequently decrease disagreement on reports of 
these symptoms. However, not all of the studies supported this hypothesis. Depressive 
symptoms such as insomnia, changes in interests, and suicidal feelings were found to be more 
likely viewed differently by the older individual and his/her informant. In addition some 
symptoms, depressed mood in particular, were observed to be consistently underreported by 
some elderly individuals with depression.  
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1.6 Present Study  
     The purpose of the present study was to further the understanding of discrepancies 
between self-reports by older patients and reports by members of their family of depressive 
symptoms in the older patient. Specifically, the present study examined relationship between 
ratings of depressive symptomatology made by the older people themselves and those made 
by their family informant as well as investigating some of the factors that influence this 
discrepancy. The study sample was comprised of non-demented secondary mental health care 
patients and their informants (family and friends) who were selected by the patients. Guided 
by the existing research it was hypothesised that:  
1. Informants would report significantly more depressive symptoms than patients. 
2. ????????????????????????????????????????????????????????????????????????????????????
a measure asking about presence/absence of depressive symptoms (GDS-15) than on 
a measure asking about frequency of these symptoms (CUDOS).  
3. ???????????????????????????????????????????????????????????????????????????????????
??? ??????????? ???????????????? ?????????? ????????? ????????? ???????????? ????????????? ????
older age.  
4. Discrepancy between patient and informant reports of depressive symptoms would be 
higher for male and non-partner informants.  
5. Finally, it was expected that rates of agreement would be higher on items that refer to 
symptoms more easily observable with clear behavioural manifestation (e.g., changes 
in appetite, sleep patterns and energy levels) than on items that referred to 
intrapsychic symptoms (e.g. feelings of guilt and worthlessness). 
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C H APT E R T W O  
2. Methods 
 
2.1 Participants   
     Study participants were recruited (1) from a one year cohort of patients admitted to the 
???????????????????????????????????????????????????????????????????hereafter referred to as 
Ward K2 or inpatient unit) and (2) from a seven-month cohort of patients admitted to a day-
hospital - the Mabel Howard Clinic (hereafter referred to as MHC or day-hospital), both 
Canterbury District Health Board services located in Christchurch, New Zealand. All 
admitted patients received written information about the study (Appendix B), but were asked 
to participate only if they were able to give an informed consent in terms of cognitive 
capacity to understand the research project and potential ability to complete depression 
questionnaires (as judged by the pa???????? ???????? ?????, the researcher, and the Ward K2 
charge nurse or the MHC clinical director). There were no other exclusion criteria. Physically 
compromised patients who were able to communicate were included in the study. All patients 
who were selected to participate in the study were given a verbal description of the study and 
an opportunity to discuss or ask any questions regarding their participation. Patients who 
consented were asked to select an informant (e.g., a family member or a close friend) and for 
permission to contact him/her. The appointed informants were phoned by the researcher and 
included in the study if they consented. ??????????????????????????????????????????????????????? 
 
2.2 Setting  
     The sites for the research - the inpatient psychiatric ward for older people (Ward K2) and 
a psychiatric day-hospital for older people - were both located at the Princess Margaret 
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Hospital (PMH) in suburban Christchurch. Both services are part of the Psychiatry Service 
for the Elderly which is the sole secondary care provider of psychogeriatric services for the 
Canterbury region of New Zealand. Referrals are received from all primary and secondary 
care sources in Canterbury and the service acts as a tertiary provider for some out-of-area 
referrals. A minimum age for the ability to utilize these services is sixty-five years.  
     ????????????????????????????????????????????????????????????????????????????????????????
disorders such as depression, bipolar disorder, and schizophrenia. Analysis of the previous 
two years of admissions (2008 & 2009) revealed that the ward has approximately 150 
admissions each year. Approximately two-thirds of admitted patients had clinically 
significant depressive symptoms. The average length of stay on the ward was 38 days. 
     The Mabel Howard Clinic is a psychogeriatric day-hospital which provides assessment, 
treatment and rehabilitation programmes. Analysis of the previous two years of admissions 
(2008 & 2009) revealed that the MHC had approximately 120 admissions each year. At least 
three quarters of admitted patients had clinically significant depressive symptoms. Clients 
typically attend weekly. The average participation in services at the MHC day-hospital was 
29.5 weeks. 
 
2.3 Measures 
     Demographic and personal information regarding the patients was obtained from each 
patient?s health file. This included the patient?????????????????????????, and contact details for 
any appointed informant. Patients completed the 15-item Geriatric Depression Scale (GDS-
15) and the Clinically Useful Depression Outcome Scale (CUDOS).  The informant rated the 
same measures, but making the rating about the patient rather than themselves. Both 
measures are available in the public domain. The Health of the Nation Outcome Scales 65+ 
(HoNOS 65+) is routinely completed by the attending clinician as a part of standard care in 
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both the Ward K2 and the MHC. The details of HoNOS 65+ for each patient were extracted 
from their health file. All of the measures employed in this study are described below in more 
detail. 
2.3.1 Geriatric Depression Scale 15- item version. 
     The GDS-15 (Sheikh & Yesavage, 1986; Appendix C) is a 15-item self-report scale that 
assesses the presence of depressive symptoms. Respondents are asked to choose the items 
that applied to them over the period of the past week and responses are provided in a yes/no 
form. The GDS-15 can be administered orally or in a written format (Parmelee & Katz, 
1990). An overall score is obtained by reverse-scoring items 1, 5, 7, 11, and 13, and then 
summing all responses. A total score ranges from 0 to 15. A recommended cut-off score in 
older medical inpatients, which is likely to differentiate between non-depressed and 
depressed patients, is 7 (Cullum, Tucker, Todd, & Brayne, 2006). The GDS-15 has sound 
psychometric properties, with moderate internal consistency/reliability of .75 ????????????
alpha) (Friedman, Marnin, & Delavan, 2005); and, in terms of criterion validity, at the cut-off 
score of 7 the sensitivity was 70.2% and the specificity was 84.2%. Nyunt and colleagues 
reported test-retest reliability over two weeks at .83 and inter-rater reliability at .94 (Nyunt, 
Fones, Niti, & Ng, 2009). 
     The GDS-15 is a short form of the GDS-30 (Yesavage et al., 1983). The GDS-30 was 
designed specifically for use with older people by excluding items assessing somatic and 
vegetative symptoms of depression and adopting a simple yes/no response format. As a 
screening instrument the GDS-30 is widely used in clinical and research settings. The 
reliability of the GDS-30 has been found to be high; an average of .84 across a range of 
studies (Keiffer & Reeses, 2002) and the concurrent validity of the GDS-30 is also high (e.g. 
Olin, Schneider, Eaton, Zemansky, & Pollock 1992). The correlation between the GDS-30 
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and the GDS-15 is .84 (Sheikh & Yesavage, 1986); therefore, in the present study the GDS-
15 was chosen as a briefer and less time engaging alternative to the GDS-30.    
2.3.2 Informant version of the G DS-15 (G DSI-15). 
     The GDSI-15 (Brown & Schinka, 2005, Appendix D) is a version of the GDS-15 but 
designed for completion by an informant, i.e., person who knows the individual being 
assessed well enough to act as an informant about their health and well-being. The GDSI-15 
???? ???? ????? ????? ???????? ?????? ?? ??????? ??? ???????? ????? ???? ??? ??????????? ??????? ???
responses and scoring principles as the GDS-15. A validation study by Brown and Shinka 
(2005) found the GDSI-15 to have sufficient internal consistency/reliability (???????????
alpha = .86) and retest reliability (r = .81), as well as good construct validity.  
2.3.3 C linically Useful Depression Outcome Scale.  
     The CUDOS (Zimmerman, Chelminsky, McGlinchey, & Posternak, 2008; Appendix E) is 
an 18-item scale which measures depression across the ????????????????????????The sixteen 
items assess the DSM-IV symptom criteria (for criteria with more than one construct, the 
subcomponents are assessed in separate questions) and two further items assess global 
perception of psychosocial impairment due to depression and overall quality of life. Answers 
are rated on a 5-point (0-4) Likert scale (0 ? not at all true/0 days, 1 ? rarely true/1-2 days, 2 ? 
sometimes true/3-4 days, 3 ? usually true/5-6 days, and 4 ? almost always true/every day). A 
total score ranges from 0 to 72 where 0 to 10 is considered to be a non-depressed range, 11 to 
20 suggests minimal depression, 21 to 30 mild depression, 31 to 45 moderate depression, and 
46 and above is likely to indicate severe depression (Zimmerman, Chelminsky et al., 2008).  
     The CUDOS is somewhat similar to the 9-item Patient Health Questionnaire (PHQ-9) 
which is a brief self-report measure assessing 9 DSM-IV symptoms of MDD using a Likert 
scale similar to the CUDOS. However, due to its brief form PHQ-9 has been criticised for not 
capturing potentially significant clinical information (Zimmerman & McGlinchey, 2008).  
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     A validation study using an adult psychiatric outpatient population by Zimmerman and 
colleagues (Zimmerman, McGlinchey, & Chelminsky, 2008), reported that the CUDOS has 
high internal consistency/reliability ????????????alpha = .90) and test-retest reliability (r = 
.92), as well as good convergent and discriminant validity. As the CUDOS is a relatively new 
measure, there are no reported studies that have employed the CUDOS in the older adult 
?????????????????????????????????????????????????.  
2.3.4 Informant version of the C UD OS (C UD OS-I). 
     The CUDOS-I (Appendix F) was constructed for the purpose of the present study by 
????????? ???? ???????? ??? ???? ??? ???? ?????? ????? ???? ??? ????????????? ???????? ???????? ??? ?????
content were made, and the format of responses and scoring principles remained the same as 
in the self-report CUDOS.  
2.3.5 The Health of the Nation Outcome Scales 65+ . 
     The HoNOS 65+ (Burns et al., 1999; Appendix G) is a 12-item clinician-rated measure 
that assesses mental and social functioning outcomes in elderly people with mental health 
problems. The recommended rating period is for the preceding two weeks for both hospital 
outpatients and inpatients at admission. Each item is rated on a 5-point scale of severity (0-4) 
as follows: 0 ? no problem, 1 ? minor problem requiring no formal action, 2 ? mild problem, 
3 ? problem of moderate severity, 4 ? severe to very severe problem. Ratings 0 and 1 are 
considered not clinically significant whereas ratings 2, 3, and 4 are regarded as clinically 
significant. The individual scale items are: Behavioural disturbance, Non-accidental self 
injury, Problem drinking or drug use, Cognitive problems, Problems related to physical 
illness or disability, Problems associated with hallucinations and/or delusions or false beliefs, 
Problems associated with depressive symptoms, Other mental or behavioural problems, 
Problems with social or supportive relationships, Problems with activities of daily living, 
Overall problems with living conditions, and Problems with work and leisure activities. 
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     The HoNOS 65+ has good inter-rater reliability and is a valid measure against other 
established scales which measure mental health problems in older people. A study by Burns 
et al. (1999) reported inter-rater reliability at .82 and moderate to high correlations of the 
individual HoNOS 65+ items with corresponding more detailed scales. Also, a New Zealand 
study by Gee, Croucher, and Beveridge (2010) reported an adequate concurrent validity and 
sensitivity to change. The HoNOS65+ is routinely collected in the Psychiatric Service for the 
Elderly, and indeed its use is mandated by the New Zealand Ministry of Health. 
     The present study employs four of the HoNOS 65+ items in order to operationalize some 
of the independent variables and to aid description of the sample. The results on item 5 
(Physical illness or disability problems) are framed as physical frailty, those on item 7 
(Problems with depressive symptoms) are operationalized as depression severity, and those 
on item 8 (Other mental and behavioural problems) as comorbidity. The results on item 6 
(Problems associated with hallucinations and delusions) are used as a descriptor of the 
presence of clinically significant hallucinations and delusions in the current sample.  
 
2.4 Procedure  
     The potential participant pool was a cohort of admissions to the Ward K2 over a one year 
period and the MHC over a seven-month period. Patients deemed appropriate for the study, 
were contacted in person by the researcher within the first two weeks of admission. After 
obtaining informed consent (consent form included in Appendix H), participants were asked 
to complete two self-report depression questionnaires, i.e., the CUDOS and the GDS-15. 
Both questionnaires were administered ????????????????????????????????????????????????????????
Ward K2 or in an interview room at the MHC. The current study was part of a larger research 
project carried out by the Psychiatry of Old Age Academic Unit at the PMH. There was no 
compensation offered to participants.  
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     For patients who consented, information was collected from an informant such as a family 
member or a friend who was appointed by the patient. The informant was contacted by phone 
by the researcher and offered a verbal explanation of the study purpose and procedure. After 
obtaining informed consent, the informant was asked to complete the GDSI-15 and the 
CUDOS-I, which were both sent out to them with a study information sheet (Appendix I) and 
a post-paid envelope. If the informant version questionnaires were not returned within two 
weeks, a remainder phone call was made.     
     ?????????? ????graphic variables, including age and gender, as well as information 
concerning medical and psychiatric comorbidity, were ?????????? ????? ??????????????????????
???????????????????????????????????????????????????????????????????????????????was collected 
at the time of obtaining consent from the patients. 
     Ethical approval for this study was granted by the Upper South A Regional Ethics 
Committee (Ethics Reference Number: URB/09/03/009; see Appendix J). 
 
2.5 Design and Statistical Analyses 
     Data were first entered into Microsoft Office Excel and then transferred into IBM SPSS 
Statistics (19.0) (2010). All data analyses were performed using SPSS. Data analyses 
comprised of descriptive statistics, t-tests, bivariate correlations, and multiple linear 
regression analyses. 
     Standard descriptive statistics were used to determine the demographic and clinical 
characteristics of the sample. Pearson product-moment correlations were calculated in order 
to assess the relationship between self-reported GDS-15 and self-reported CUDOS 
depression levels, as well as between informant-reported GDS-15 and informant-reported 
CUDOS depression scores. Two dependent t-tests were calculated to compare the self-report 
and informant ratings of depression severity on the GDS-15 and the CUDOS respectively. A 
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discrepancy score, namely the total score difference between the self-report and informant 
report GDS-15, was created by subtracting a total GDSI-15 score from a total self-report 
GDS-15 score; negative values indicate that the informant endorsed more depressive 
symptoms than the patient. A corresponding procedure was applied to create a total 
discrepancy score between the self-report and informant report CUDOS measures. The 
bivariate association of each independent variable with two dependent variables (a total score 
difference) was examined using independent t-tests and the Pearson product-moment 
correlation as appropriate. Guidelines for the interpretation of Pearson correlation coefficient 
were adopted as follows: values between 0 to .29 regarded as little if any correlation, between 
.3 to .49 as small or weak correlation, between .5 and .69 as moderate correlation, between .7 
to.89 as strong correlation, and values between .9 and 1 as very strong correlation (Cohen, 
1988). 
     Taking into account small sample size and a consequent need to reduce the number of 
predictors, only those independent variables which were found to be significantly associated 
with dependent variables were entered into multivariate linear regression. The p value for 
including the independent variables in to the regressions was p < .05. Subsequently, two 
separate simultaneous multiple regressions were conducted. The first one used the total GDS-
15 discrepancy score as a criterion and independent variables that were significantly 
associated with the total GDS-15 discrepancy score as predictors. Correspondingly, a second 
regression used the total CUDOS discrepancy score as criterion and independent variables 
that were found to be significantly associated with the total CUDOS discrepancy score as 
predictors.  
     Cohen's kappa coefficients were calculated to assess the proportion of agreement, beyond 
the amount which is expected by chance alone, between patients and informant responses on 
each item of the GDS-15 and the CUDOS. The range for kappa is from less than 0 to 1, with 
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a value of 1 indicating perfect agreement. Guidelines for interpreting the kappa coefficient 
suggest that kappa values greater than 0.8 indicate almost perfect agreement, values between 
0.6 and 0.8 indicate substantial agreement, values between 0.4 and 0.6 indicate moderate 
agreement, values between 0.21 and 0.4 indicate fair agreement, values between 0.2 and 0.0 
indicate slight agreement, and values less than 0.0 indicate poor agreement (Landis & Koch, 
1977). The standard error used for kappa is that given by Fleiss, Cohen, & Everitt (1969). 
Fleiss and colleges (1969) recommended that when the categories are nominal, Cohen's 
simple unweighted coefficient is the only form of kappa that can be used meaningfully, 
whereas when the categories are ordinal the weighted kappa coefficients should be computed. 
Considering that the GDS-15 is a nominal scale and the CUDOS is an ordinal scale, the 
unweighted kappa coefficients were calculated for all of the GDS-15 items and the weighted 
kappa coefficients were calculated for the CUDOS items.  
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C H APT E R T H R E E  
3. Results 
 
3.1 Descriptive Character istics of the Sample 
3.1.1 Response rate. 
     The sample analysed in the present study consisted of patients for whom an informant 
rating was successfully collected. Where the same individual had data collected on both the 
inpatient ward and the day-hospital, only data from the inpatient ward was used in the 
analysis.  
     For the inpatient ward (K2) 117 patients were noted as admitted, of whom 44 (45%) 
completed the questionnaire. Of those who did not participate approximately a quarter were 
not available or excluded by staff (e.g. discharged, deceased, did not speak English, 
cognitively impaired or too unwell), while approximately three quarters declined. Informant 
questionnaires were successfully gathered for 15 (34%) of the participants (e.g. they were 
willing and able to nominate an informant, who was in turn contactable and willing to 
complete the questionnaire).  
     For the day-hospital (MHC) 90 patients were admitted, of whom 90% (81) completed the 
questionnaire. Six were excluded from this analysis because they had been participated on 
K2. Collateral source information was successfully gathered for 21 (28%) of the remaining 
participants. 
3.1.2 Description of sample. 
     Table 1 summarises the demographic information and the presence of clinically significant 
psychiatric symptoms for the inpatient Ward K2 (N = 15) and the day-hospital MHC (N = 21) 
samples separately as well as for the entire sample. Visual inspection of descriptive 
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characteristics data suggests that their distributions were similar for the Ward K2 and the 
MHC samples. Between-groups comparison of demographic and clinical descriptive 
variables revealed no significant difference in age, gender, ethnicity, and level of depression. 
However, there was a significant difference in anxiety level [t(34) = -2.59, p < .05] and 
presence of clinically significant hallucinations and delusions [t(34) = 2.53, p < .05]. Anxiety 
levels displayed by patients from the MHC were clinically significantly higher (M = 1.95, SD 
= 1.16) than those of Ward K2 patients (M = 1.27, SD = 1.44). At the same time, patients in 
Ward K2 displayed clinically significant hallucinations and delusions (M = 1.2, SD = 1.42) to 
a greater degree than those in the MHC (M = .1, SD = .44). Despite these differences between 
the two locations, considering the small overall sample size, the main data analyses were 
subsequently conducted using the total sample.  
     The average age of all of the patients was 76 years of age and all of them endorsed NZ 
European ethnicity. A majority of patients were females (64%) and most of them had 
clinically significant symptoms of depression (72%) and anxiety (61%) as assessed by the 
HoNOS 65+. Only some of the patients (22%) were recognised to have clinically significant 
hallucinations and delusions on the HoNOS 65+. As none of the patients had a diagnosis of 
cognitive impairment it was assumed that all of the patients had normal cognitive 
functioning.  
 
3.2 Description of Variables 
     The following variables were investigated as potential predictors of any differences 
between self and informant reports of depressive symptoms: Age, Gender, Location 
(inpatient or day-hospital), Symptoms of Depression, Physical Frailty, Psychiatric 
Comorbidity, ????????????????????????, and ??????????? Gender.  
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Table 1 
Descriptive Characteristics of the Ward K2 Sample, the Mabel Howard Clinic (MHC) 
Sample and the Total Sample 
 
Characteristics K2 Sample (N=15) 
Mean (SD) or n (%)  
MHC Sample (N=21) 
Mean (SD) or n (%) 
Total Sample 
(N=36) 
Mean (SD) or n (%) 
Gender    
      Female % 10 (67) 13 (62) 23 (64) 
      Male % 5 (33) 8 (38) 13 (36) 
Ethnicity    
     NZ European 15 (100) 21 (100) 36 (100) 
     NZ Maori 0 (0) 0 (0) 0 (0) 
Age (years) 75.3 (6.4) 76.1 (6.8) 75.8 (6.5) 
HoNOS 65+ 
Symptoms 
   
     Depression % 10 (67) 16 (76) 26 (72) 
     Anxiety % 6 (40) 16 (76) 22 (61) 
Hallucination and     
Delusions % 
 
7 (47) 1 (5) 8 (22) 
 
 
Age of patients was computed by subtracting their date of birth from the admission date to 
either Ward K2 or the MHC. Age (i.e., current age), was used in all of the analyses as a 
continuous variable. Gender and Location were dichotomised (Gender: 0 ? female, 1 ? male; 
Location: 0 ? Ward K2, 1 - MHC). Comorbidity was operationalized as the level of clinically 
significant anxiety symptoms as measured by the clinician-rated HoNOS 65+. Symptoms of 
Depression were also measured with HoNOS 65+ and operationalized as the level of 
clinically significant symptoms of depression. Both Symptoms of Depression and 
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Comorbidity were treated as continuous variables. Descriptive characteristics of Age, 
Gender, Location, Symptoms of Depression, and Comorbidity are presented in Table1.  
     The Physical Frailty score was defined as the level of physical illness or disability as 
assessed by HoNOS 65+ and it was employed in all of the analyses as a continuous variable. 
Sixty seven percent of all of the patients had clinically significant physical health problems 
associated with restriction of their activity or mobility. The distribution of Physical Frailty 
was similar for Ward K2 and the MHC. Additionally, between-groups comparison revealed 
no significant difference in levels of Physical Frailty.   
     ?????????????? ????????????? ??? ???????????????? ??????????????? ???????????? ????????????????
and dichotomised as partner or non-partner. A small sample size did not allow for a further 
differentiation of the Source Type. Thirty six percent (n = 13) o?? ??????????????????????????
partners. The non-partner category comprised of daughters (n = 11), sons (n = 4), siblings (n 
= 3), friends (n = 3), a nephew (n = 1), and an ex-partner (n = 1). The Source Gender was the 
gender of the appointed informant. Sixty seven percent of informants were females.  
 
3.3. Descr iptive Data for Measures of Depression 
3.3.1 Distribution of scores. 
     Figures 1 ? 4 illustrate the distribution of scores on both self and informant versions of 
both GDS-15 and CUDOS. As shown in Figure 1 and 4, the scores for the self-reported GDS-
15 and the informant reported CUDOS appear to be relatively normally distributed, while the 
scores for the informant-rated GDS-15 are negatively skewed (Figure 2). Positive skew is 
evident for the self-reported CUDOS (Figure 3).  
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F igure 1. Distribution of scores on self-rated GDS-15. Dotted line marks a cut-off point of 7 that differentiates 
between non-depressed and depressed ranges. 
 
 
 
F igure 2. Distribution of scores on informant-rated GDS-15. Dotted line marks a cut-off point of 7 that 
differentiates between non-depressed and depressed ranges. 
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F igure 3. Distribution of scores on self-rated CUDOS. Dotted lines indicate cut-off points between non-
depressed, minimal, mild, moderate, and severe depressive symptomatology (11, 21, 31, and 46 respectively). 
 
 
 
F igure 4. Distribution of scores on informant-rated CUDOS. Dotted lines indicate cut-off points between non-
depressed, minimal, mild, moderate, and severe depressive symptomatology (11, 21, 31, and 46 respectively). 
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3.3.2 Measures of central tendency.    
     Scores on the GDS-15 were summed to provide a total score for self-reported depressive 
symptoms with an observed range of 0 through to 15; the mean was 6.97 (SD = 3.79), and the 
median was 6.78. Both the mean and the median are approaching the cut-off score of 7 that 
differentiate between non-depressed and depressed individuals. Also, scores on the 18 items 
of the self CUDOS were summed to provide a total score with an observed range of 2 
through to 59, the mean was 24.38 (SD = 15.82), and the median was 20.5. The mean is 
within mild depression severity range and the median within minimal depression severity 
range.  
     Correspondingly, scores on the GDSI-15 were summed to provide a total score for 
informant-reported symptoms of depression with an observed range of 0 through to 15, a 
mean of 9.38 (SD = 4.58), and median of 11.39. Scores on an informant version of CUDOS 
were also summed to provide a mean total score of 31.27 (SD = 16.56), with an observed 
range of 4 through to 59, and median of 30.5.  
3.3.3 Correlations. 
    Correlations were conducted to assess how scores on the measures related to each other. 
The first pair of correlations assessed the association across the two instruments for ratings 
made by the same rater.  Pearson product-moment correlations between the total self-report 
GDS-15 and the total self-report CUDOS were calculated. There was a significant (criterion p 
< .05), moderate positive relationship between these self-report measures, r(34) = .64, (p < 
.001), which suggests that patients reports of depressive symptoms are fairly consistent on 
both questionnaires. Whereas Pearson product-moment correlation between the total 
informant-report GDS-15 and informant-report CUDOS was r(34) = .82, (p < .001), 
revealing a strong positive, significant relationship between scores on these questionnaires.  
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F igure 5. Scatter plot representing correlation between self-reported GDS-15 and self-reported CUDOS. 
 
 
 
 
F igure 6. Scatter plot representing correlation between informant-reported GDS-15 and informant-reported 
CUDOS.  
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????? ?????????? ????? ???????????? ???????? ??? ??????????? ????????? ???? ??????????? ??????? ?????
measures. Figures 5 and 6 present scatter plots representing correlation between self-reported 
GDS-15 and self-reported CUDOS, and between informant-reported GDS-15 and informant-
reported CUDOS respectively. Both of these plots show positive correlation between 
questionnaires and display lack of other systematic variation between them. 
     The second set of correlations assessed the association between the level of depressive 
symptoms rated by the individual and that rated by their informant. Pearson product-moment 
correlation was also performed between a self GDS-15 total and an informant GDSI-15 total, 
using an alpha level of .05. A moderate, positive relationship between a self GDS-15 total 
and an informant GDSI-15 total was significant, r(34) = .65 ( p < .001), suggesting that 
?????????? ???? ???????????? ???????? ??? ??????????? ????????? ?????? ???-15 were similar. 
Similarly, Pearson product-moment correlation was performed between a total self-report 
CUDOS and a total informant CUDOS, using an alpha level of .05. A small positive 
relationship between a total self-report CUDOS and informant-report CUDOS was 
significant, r(34) = .39, (p ?????????????????????????????????????????????????????????????????????
of depressive symptoms are relatively poorly correlated with self-reported levels of 
depression when using the CUDOS.      
     Figures 7 and 8 present scatter plots representing correlation between self-reported GDS-
15 and informant-reported GDS-15, and between self-reported CUDOS and informant-
reported CUDOS respectively.  
     In summary, there was a moderate to strong relationship between the two instruments 
when rated by the same person. For the GDS-15 there was a moderate relationship between 
patient and informant ratings whereas for the CUDOS there was s significant but smaller 
relationship between patient and informant ratings. 
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3.4 Differences between Self and Informant Reports of Depressive 
Symptoms 
     To test the first hypothesis that informants would report significantly more depressive 
symptoms than patients, dependent t-tests were calculated to compare the self-report and 
informant ratings of depression. This was conducted for each of the two depression measures 
(the GDS-15 and the CUDOS) separately. The comparison across the two analyses allowed 
assessment of the second hypothesis that t??? ???????? ???????????? ???????? ?????????? ????
???????????? ???????? ?????? ??? ?????? ??? ?? ???????? ??????? ?????? ????????????????? ???
depressive symptoms (GDS-15) than on a measure asking about frequency of these 
symptoms (CUDOS). Assumptions of normality were met.   
     For the GDS-15, the mean total score for the self-report GDS-15 (M = 6.97, SD = 3.97) 
was lower than the mean total score for the informant version of the GDS-15 (M=9.38, 
SD=4.59). The mean total discrepancy score of -2.41 between the self and informant reports 
of depression was found to be statistically significant from zero [t(35) = -4.05, p < .001] with 
a 95% confidence interval of (-3.62)?(-1.20). The obtained effect size for information source 
was d =  .67 (medium; Cohen, 1988) for the GDS-15.  
     Regarding CUDOS, mean for the total self-report CUDOS (M = 24.38, SD = 15.82) was 
lower than the mean for the total score for the informant version of CUDOS (M = 31.27, SD 
= 16.56). The mean total discrepancy score of -6.89 between the self and informant reports of 
depression was also found to be statistically significant [t(35) = -2.38, p = .023] with a 95% 
confidence interval of (-12.76)?(-1.01). The obtained information source effect size (d = .40) 
was in between the conventional boundaries of a small and a medium effect size. 
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F igure 7. Scatter plot representing correlation between self-reported GDS-15 and informant-reported GDS-15.  
 
 
 
 
 
F igure 8. Scatter plot representing correlation between self-reported CUDOS and informant-reported CUDOS.  
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     Overall, both t-tests indicated that informants rated greater amount of depressive 
symptoms than did the individual themselves. Comparing effect sizes, that discrepancy was 
greater for the GDS-15 than for the CUDOS.   
 
3.5 Associations between Independent Variables and Total Discrepancy 
Scores between Self and Informant Reports of Symptoms of Depression 
     It was hypothesised that discrepancy between p????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????
psychiatric comorbidity, and older age. Also, discrepancy between patient and informant 
reports of depressive symptoms was expected be higher for male and non-partner informants.  
As a first step correlations or t-tests between the discrepancy score and each of these 
variables were conducted. Table 2 presents the associations between the independent 
variables and the GDS-15 and the CUDOS total discrepancy scores, as well as their 
significance value.   
     For the GDS-15, p????????????????????Psychiatric Comorbidity were found to be 
significantly associated with the GDS-15 total discrepancy score. The difference between self 
and informant GDS-15 was more likely to be higher for male patients than for female patients 
and was ????????????????????????????????????????????????????????????????psychiatric 
comorbidity.  
     ??????????????????????????ender and Location (inpatient, day-hospital) were found to be 
significantly associated with the CUDOS total discrepancy score. This indicates that for male 
patients the difference between self and informant CUDOS is likely to be higher than for 
female patients and also this difference is likely to be higher for patients from the day-
hospital (MHC) than for patients from the inpatient Ward K2.  
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Table 2 
Association between Independent Variables and total discrepancy scores between self and 
informant GDS-15 and CUDOS 
 
Independent 
Variable 
Association with GDS-
15 total discrepancy 
scores 
Association with 
CUDOS total 
discrepancy scores 
  r p  r p 
Age   .088 ns  .032 ns 
Symptoms of 
Depression 
 
 -.022 ns  .185 ns 
Physical F railty  -.093 ns  -.011 ns 
Comorbidity  .380 .022*  .124 ns 
  t p  t p 
Gender   2.114 .042*  2.079 .045* 
Location  -.100 ns  2.617 .013* 
Source Type  .264 ns  1.383 ns 
Source Gender   .126 ns  .466 ns 
Note. * p < .05, ns ? non-significant    
 
3.6 Prediction of Total Discrepancy Scores between Self and Informant 
Reports of Symptoms of Depression 
     As a second step to examine the factors associated with discrepancy scores, two separate, 
simultaneous multiple regressions were conducted using the GDS and the CUDOS 
discrepancy scores as criteria. Gender and Comorbidity were used to predict the GDS-15 total 
discrepancy score and Gender and Location were used to predict the CUDOS total 
discrepancy score (because only these variables were found to be significantly associated 
with the respective discrepancy scores in univariate analyses; see above).  
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3.6.1 Prediction of the G DS-15 total discrepancy scores. 
     A simultaneous multiple regression was conducted using the GDS-15 total discrepancy 
??????? ??? ?? ?????????? ???? ?????????? ??????? ???? Psychiatric Comorbidity as predictive 
variables. Analysis of assumptions revealed no outliers with a standard residual > 3, and no 
outliers with an extreme Mahalanobis distance score > 13.816 (p < .001). Table 3 displays the 
unstandardised regression coefficients (B), the standard error of the unstandardised regression 
coefficients (SD??? ????????????? ??????????? ????????????? ????? ???? ?????? ????????????? ??????? ?p). 
The analysis resulted in R = .449, R 2 = .204, adjusted R2 = .153, F(2, 33) = 4.160, (p = .024). 
     ???????? ?????????? ??????? ???? Psychiatric Comorbidity scores were significant, unique 
predictors of the GDS-15 total discrepancy scores. 
 
Table 3 
Simultaneous Multiple Regression of Gender and Comorbidity as Predictors of the GDS-15 
Total Discrepancy Score  
 
Variable B SE ? p 
Gender -1.831 1.196 -.250 .135 
Comorbidity .835 .445 .306 .069 
Constant -3.142 1.109  .008 
Note. Adjusted R 2= .153 
 
3.6.2 Prediction of the C UD OS total discrepancy scores.  
     A second simultaneous multiple regression was conducted with the CUDOS total 
????????????????????????????????????????????????????????????????????(inpatient, day-hospital) 
as predictive variables. Analysis of assumptions revealed no outliers with standard residual > 
3, and no outliers with an extreme Mahalanobis distance score > 13.816 (p < .001).  
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     Table 4 displays the unstandardised regression coefficients (B), the standard error of the 
unstandardised regression coefficients (SD), standardised reg???????? ????????????? ????? ????
their significance levels (p). The analysis rendered R = .517, R 2= .268, adjusted R2 = .223, 
F(2, 33) = 6.031, (p = .006). 
     Both Gender and Location were significant, unique predictors of CUDOS total 
discrepancy scores. As noted above discrepancy between self and informant CUDOS was 
greater for male than for female patients and the discrepancy was higher for patients from the 
MHC day-hospital than for patients from the inpatient K2 Ward. 
 
Table 4 
Simultaneous Multiple Regression of Gender and Location as Predictors of the CUDOS 
Total Discrepancy Score  
 
Variable B SE ? p 
Gender -11.284 5.316 -.317 .041* 
Location -13.682 5.179 -.394 .013* 
Constant 5.171 4.330  .241 
Note. Adjusted R 2= .223, * p < .05 
 
3.7 Item-level Inter rater Reliability for the Self and Informant G DS-15 and 
the Self and Informant C UD OS 
     The fifth hypothesis was that rates of agreement would be higher on items that refer to 
symptoms more easily observable with clear behavioural manifestation (e.g., changes in 
appetite, sleep patterns and energy levels) than on items that referred to intrapsychic 
symptoms (e.g. feelings of guilt and worthlessness). To assess this, an interrater reliability 
analysis using kappa statistics was performed to determine the rates of agreement among 
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raters on each GDS-15 and CUDOS items. The unweighted kappa coefficients, between the 
self and informant rating, for each of the GDS-15 items were calculated and for each of the 
CUDOS items the weighted kappa coefficients between patients? and informants? rating were 
computed. Based on the previous research, each of the GDS-15 and CUDOS items were 
arbitrary categorized as items relating to observable or intrapsychic symptoms of depression. 
Some of the GDS-15 items were categorized as both because the way they were phrased 
related to both types of symptoms.  
3.7.1 Inter rater reliability for the G DS-15.  
     The unweighted kappa coefficients for each of the GDS-15 items, as well as their standard 
errors of measurement and confidence intervals are presented in Table 5. Of the 15 items for 
???????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????? 
3.7.2 Inter rater reliability for the C UD OS. 
     The kappa coefficients with linear weighting, between the self and informant rating, for 
each of the CUDOS items, their standard error of measurement, and confidence intervals are 
presented in Table 6. Of the 18 CUDOS items, agreement was moderate ?????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????????
items. 
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Table 5  
Unweighted Kappa for the GDS-15 
 
GDS  
Item 
Observed  
Kappa 
Standard  
Error 
.95 Confidence 
Interval 
Lower 
Limit 
Upper 
Limit 
 
1??????????????????????? .489*** .141 .212 .765 
2???????????????????? .127* .172 < 0 .464 
3???????????????????? .395** .159 .083 .707 
4??????????? .384** .141 .108 .660 
5?? ?????? .157* .131 < 0 .414 
6????????????????????? .056* .153 < 0 .356 
7?? ???????????????? .264** .140 < 0 .538 
8???????????????? .243** .175 < 0 .586 
9???????????????????? .406** .156 .100 .712 
10?? ???????????????? .100* .161 < 0 .415 
11?????????????????????? .427*** .135 .162 .692 
12????????????????? .591*** .136 .324 .857 
13?????????????????? .364** .180 .011 .717 
14???????????????? .118* .130 < 0 .373 
15????????????????? .343** .157 
 
.035 .651 
Note. *slight agreement, **fair agreement, ***moderate agreement?????????????????????????
???????????????symptoms 
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Table 6 
Kappa with Linear Weighting for the CUDOS  
 
CUDOS  
Items 
Observed  
Kappa 
Standard 
 Error 
.95 Confidence 
Interval 
Lower 
Limit 
Upper 
Limit 
 
1???????????? ????? .182* .093 < 0 .364 
2???????????????????? .128* .119 < 0 .362 
3?????????????????????? .313** .109 .099 .527 
4??????????????????????? .027* .085 < 0 .193 
5??????????????????? .336** .118 .105 .566 
6??????????????????? .140* .157 < 0 .449 
7?? ???????????????? .167* .114 < 0 .389 
8?? ?????????????????? .190* .113 < 0 .412 
9?????????????? .251** .104 .046 .455 
10????????????????????? .111* .125 < 0 .357 
11??????????????????????? .061* .129 < 0 .315 
12?????????????????????????????? .233** .098 .041 .425 
13?????????????????? .134* .113 < 0 .355 
14. thoughts about ??????? .453*** .112 .233 .674 
15????????????????????? .441*** .134 .177 .704 
16???????????????? .209** .111 < 0 .427 
17????????????????????????????? .291** .097 .101 .481 
18??????????????????? .129* .128 < 0 .379 
 
Note. *slight agreement, **fair agreement, ***moderate agreement?????????????????????????
??????????????????????? 
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C H APT E R F O UR 
4. Discussion 
     The present study examined discrepancy between reports of depressive symptoms of 
elderly individuals and their family or friends as informants. It also looked at factors 
potentially affecting this discrepancy related to characteristics of the older individual, 
informant, type of measure assessing depression, and type of depressive symptoms. 
Description of fin????????????????????????????????????????????????????????????????????????????????
practice and research, and possible future direction for further research are described below.  
 
4.1 Summary of F indings  
1    Did informants report significantly more depressive symptoms than patients? 
The present study found that there was a significant discrepancy between patient and 
family informant reports of depressive symptomatology. Informants reported significantly 
more depressive symptoms than the psychogeriatric patients themselves on two 
depression measures, namely the GDS-15 and the CUDOS. 
 
2 Was the overall discrepancy between patient?s and informant?s ratings lower on a 
measure relating to presence/absence of depressive symptoms (GDS-15) than on a 
measure relating to frequency of these symptoms (CUDOS)?  
In contrast to expectations, the discrepancy was greater on the GDS-15 than on the 
CUDOS.  
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3 Was the discrepancy between patient?s and informant?s reports of depressive symptoms 
positively correlated with patient?s physical frailty, psychiatric comorbidity, and older 
age? 
??????????????????? ???????????????????????????????????????? ?????????????????????????????
between patient and informant reports of depressive symptomatology on either GDS-15 
or CUDOS. 
????????????????atric comorbidity was positively associated in a univariate analysis with 
discrepancy of reports for the GDS-15. However, psychiatric comorbidity was not a 
significant unique predictor of GDS-15 discrepancy after regression analysis was 
??????????? ????????s psychiatric comorbidity did not predict discrepancy in reports on 
CUDOS.  
 
4 Was discrepancy between patient and informant reports of depressive symptoms higher 
for males and for non-partner informants?  
?????????????????????????????????????????????????????tient did not predict the magnitude of 
discrepancy between patient and informant reports of depressive symptomatology on 
either the GDS-15 or the CUDOS. 
There was a significantly greater discrepancy score for male participants for both the 
CUDOS and GDS-15 in univariate analyses. Participant gender remained a significant 
unique predictor for the CUDOS score in a regression analysis, but not for the GDS-15. 
 
5 Were the rates of agreement higher on items that referred to symptoms more easily 
observable with clear behavioural manifestation (e.g., changes in appetite, sleep patterns 
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and energy levels) than on items that referred to intrapsychic symptoms (e.g. feelings of 
guilt and worthlessness)? 
Surprisingly, rates of agreement were somewhat higher on items that assessed suicidal 
ideation and intent as well as feelings of worthlessness and life satisfaction as opposed to 
items that assessed symptoms with clear behavioural manifestation.  
The present study took place at two locations, a day-hospital and an inpatient ward. The    
discrepancy scores were greater for the day-hospital participants than for the inpatient 
participants, however this was observed for the CUDOS only. 
 
4.2 Interpretation and comparison with previous research  
4.2.1 Overall discrepancy between patient and informant reports.  
     The present study demonstrated significant discrepancies between self- and informant 
reports of depressive symptoms on both depression questionnaires that were used to assess 
these symptoms. These findings are consistent with several previous studies (e.g. Burke et al., 
1998; Davison et al., 2009; Snow, Cook, Lin, Morgan, & Magaziner, 2005).  
     Importantly, it was confirmed that informants consistently reported significantly more 
depressive symptoms than did patients themselves on both the GDS-15 and the CUDOS. In a 
different sample; AD and cognitively intact community-dwelling older individuals, Burke et 
al. (1998) also found than informants consistently perceived more depressive symptoms than 
subjects on self-report questionnaires. Similarly, McAvay et al. (2004) in a sample of non-
demented medical patients and Teri and Wagner (1991) in a sample of AD patients reported 
that overall, informants tended to report more depressive symptoms than patients. However 
both of these studies used clinician-rated methods of assessing depressive symptoms.  
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     Not all of the studies are consistent with present findings. Bassett and colleagues (1990) 
did not find any overall significant differences between community-dwelling older women 
and their informants ratings of depression on CES-D. It is possible that the overall difference 
was non-significant in their study due to low variability in depression scores, as the majority 
of their sample scored within the non-depressed range (444 women out of 538) and the 
overall mean score for self-report CES-D was considerably low (M = 7.49; CES-D possible 
score range 0 to 60). Overall, the current study is consistent with previous studies and 
provides further evidence that family members of non-demented patients display an overall 
tendency to report more depressive symptoms than patients on self-reported depression 
scales. Considering that the present study was carried out in a secondary care psychogeriatric 
setting, it further demonstrates that this tendency is not only present among community-
dwelling or medically ill individuals but also among individuals with mental health 
difficulties.    
4.2.2 Discrepancy across measures 
     It was hypothesised that because of its dichotomous response format that asks about 
presence/absence of symptoms, GDS-15 would be easier to rate and consequently the 
discrepancy in reports would be lower than on CUDOS which asks about frequency of 
symptoms. Contrary to initial predictions, the discrepancy between reports of depressive 
symptoms was found to be greater on the GDS-15 than on the CUDOS. This was indicated 
by a medium effect size for total discrepancy scores on GDS-15 as compared to small 
approaching medium effect size for total discrepancy scores on CUDOS.  
     It is possible that greater discrepancy is due to specific differences between GDS-15 and 
CUDOS. The GDS-15 does not include any items that asses somatic or suicidal symptoms of 
depression as these were excluded by scale authors to increase accuracy of geriatric 
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depression assessment, nor does it specifically ask about depressed mood. In addition, closer 
analysis of the content of some of the GDS-15 items makes it questionable whether these 
assess a singular construct of depression. ????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????as an assessment of anxiety. Moreover, several items such 
?????????????????????????????????????????? ????????????????? ?????? ??? ????????????? ????????????
???????????????????????? ??? ???????? ?????????????????????? ??????????????????????????????????
life related to depression, anxiety, or any other mental health problem. The CUDOS, on the 
other hand, asks explicitly for all of the DSM-IV-???????????????????????????????????????????
??? ??????????? ??? ???????? ?????? ???????Furthermore, the item assessing impairment clearly 
states that it is related ??? ??????????? ?????????? ?????????? ???? ????? ????? ????????? ???
????????????????????????????????????????????????????????????????????????????????????????????????
is possible that ambiguity of the GDS-??? ?????? ?????????? ???? ?????????? ??? ????????
discrepancy. 
     In addition, GDS-15 items are phrased in present tense, which can potentially increase 
discrepancy in two ways. Firstly, some of the questions when asked in present tense appear to 
?????????????????????????????????????????????????????????????????????????????????????????????
you think that most people are better off ????? ???? ??????? ? ????? ?????? ???????????? ????????
increase ambiguity around what is being assessed through these questions and consequently 
increase the discrepancy. Secondly, the one-week time frame regarding the presence of 
depressive symptoms is specified only in the first sentence and questions that follow are in 
present tense, which creates a confusion around the specific period of time that GDS-15 items 
relate to. Thus, it is possible that not all of the patients and informants had a one week 
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timeframe in mind when answering all of the GDS-15 questions. This could have additionally 
increased the discrepancy in reports observed on the GDS-15.  
     Although the possible  range of scores is greater on CUDOS than it is on GDS-15, it is 
worth noting that variability of scores on CUDOS appears to be much greater than on GDS-
15 for both self- and informant reports. Thus, it is possible that a higher standard deviation of 
scores on CUDOS decreased an overall effect size for discrepancies of self- and informant 
reports observed on CUDOS and subsequently the effect size observed for GDS-15 appeared 
to be relatively higher. 
4.2.2 Discrepancy and patient characteristics. 
     ?????????? ????? ??????? ???? ?????ficantly associated with discrepancy in reports of 
depressive symptoms on both GDS-15 and CUDOS. However, it significantly predicted this 
discrepancy only when CUDOS was used. It has been noted that affective symptoms are 
often underreported by older individuals due to a variety of reasons such as concern among 
older people about the stigma of mental illness, lack of insight into their mood, a tendency to 
normalize their depressed mood, or a reluctance to disclose affective symptoms (e.g. Brodaty 
et al., 2005; Davison et al., 2009; Lyness et al., 1995). Although not conclusive, there is also 
some evidence suggesting that males in general have a tendency to underreport depressive 
symptoms (e.g. Blair-West, Cantor, Mellsop, & Eyeson-Annan, 1999; Steffens et al., 2000). 
Thus, this raises a possibility that in the present study older males had a tendency to 
underreport depressive symptoms, which consequently affected the discrepancy self- and 
informant reports of depressive symptoms.  
     Greater psychiatric comorbidity was positively associated with discrepancy of reports of 
depressive symptoms on the GDS-???????????? ????? ?????????? ??????????? ?????????? ?????
comorbidity did not significantly predict this discrepancy in reports. More participants would 
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be needed to tease out the inter-relationship between psychiatric co-morbidity and gender to 
help interpret this pattern of results. However combining a possibility that males have a 
tendency to underreport depressive symptoms with ambiguity of the GDS-15 items, it raises a 
possibility that with greater comorbidity informants would endorse more symptoms on the 
GDS-15 than patients. This in consequence would increase a discrepancy between GDS-15 
scores of male patients with greater comorbidity and their informants.  
     ?????????? ????????? ????????? ????? ???? ????????? ??? ??????????? ???? ???? ???????? ????????????
between patient and informant reports of depressive symptoms on either of the depression 
??????????????????????????????????????????????????????????????????????????nctional disability 
in differences between reports of depressive symptoms (McAvay et al., 2004) used more 
comprehensive measures to assess these constructs than these used in the present study. It is 
possible that physical frailty operationalized as a score on a single HoNOS 65+ item was too 
simplistic and not sufficient to detect its influence on discrepancy between patient and 
informant reports of depressive symptoms.   
    A study by Cacchione et al. (2003), and another by Ross et al. (1997), found that an 
????????????????????????????????????????????????????????????????????????????????????????????????
depression. However, the patient sample in both of these studies was comprised of 
individuals with dementia. Thus, it is possible that an increase in patient age was to some 
extent confounded with an increase in dementia severity. This could mean that greater 
difference in reports was potentially reflected by the ?????????? ????????? ??? ??????????? ???
reports and not necessarily by their greater age. If that was the case, a lack of significant 
???????????? ?????????????????? ???? ???? ????????????????? ???????????? ??? ????- and informant 
reports of depressive symptoms would not be surprising as none of the patients from the 
present sample were diagnosed with dementia.  
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    None of the studies from the domain of ?????? ????????? ??????? ??????? ????????? ???? ????
purpose of the present study implicated depression severity as a predictor of discrepancy 
between patient and informant reports of depressive symptomatology. However, depression 
severity was explored in a present study as there is some evidence in adult mental health 
literature that it was significantly associated with discrepancies between self- and clinician-
rated depression (Carter, Frampton, Mulder, Luty, & Joyce, 2010). More relevant studies 
with elderly samples are needed to be able to put a non-significant result regarding depression 
severity into a meaningful perspective.  
     Location was included in analysis in order to account for any possible differences between 
MHC and Ward K2. The discrepancy between patient and informant reports of depressive 
symptomatology was predicted by location; discrepancy was greater for patients from the 
MHC day-hospital than for patients from Ward K2. This effect was only observed when 
depressive symptoms were assessed using CUDOS, and not when using the GDS-15. It is 
possible that greater discrepancy in depressive reports on CUDOS observed in MHC was due 
to an interplay between the ambiguity of the GDS-15 and differences between the samples in 
the patterns of presenting symptoms, such as the greater prevalence of anxiety in the day-
hospital setting and the higher prevalence of the more easily differentiated psychosis in the 
inpatient setting.  
4.2.3 Discrepancy and informant?s characteristics.  
     It was proposed that the discrepancy between self- and informant-reported symptoms of 
depression would be greater for male and non-partner informants. However, neither 
?????????????????????????????????????????????????????????????????????crepancy.  
     The m??????????????????????????? ?????????????????????????????? ???????????????????????? ????
patient as predictors of discrepancy in reports of depressive symptoms and those that did 
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found mixed results. Burke et al. (1998) did not find any significant associations between 
type of relationship between patient and informant, and the magnitude of discrepancy 
between their reports of depressive symptoms. The type of the relationship predicted the 
discrepancy in reports in studies by Bassett et al. (1990) and Cacchione et al. (2003). 
However, Cacchione et al. (2003) was not concerned with a comparison of depressive 
symptoms, but instead ?????????????????????????????????????????????????????   
     ???????????????????????????????????????????????????ing a significant effect on differences 
between informant and older individual ratings was a study by Bassett et al. (1990) and their 
sample was comprised entirely of women. Thus, it is possible that the significant effect for 
?????????????????????????????ome extent reflect gender homogeneity of the initial sample and 
would not be observed if the sample included both sexes. This notion is to some extent 
supported by a study by McAvay et al. (2004) comprised of both men and women, in which 
they found a lack ??????????????????????????????????????????????????????????????????????.  
4.2.5 Discrepancy for individual items  
     Overall, rates of agreement were mostly fair on the GDS-15 and slightly on the CUDOS. 
The highest kappa agreement was moderate and it was obtained only on three GDS-15 items 
and two CUDOS items. The content of these items related to feelings of worthlessness and 
life satisfaction on the GDS-15, and suicidal ideation and intent on the CUDOS. These results 
are rather unexpected and contrary to the hypothesis of the present study. It was expected that 
rates of agreement would be higher on items that refer to symptoms with clear behavioural 
manifestation (e.g. changes in appetite, sleep patterns and energy levels) than on items that 
referred to intrapsychic symptoms (e.g. feelings of guilt and worthlessness). These 
hypotheses were mostly based on a study by McDade-Montez et al. (2008) which supported a 
visibility effect and concluded that items used in assessment with informants should be 
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selected on the basis of their easiness to rate. However, support for a visibility effect does not 
exclude a possibility that some items might be perceived as difficult to rate while the 
informant might have an appropriate knowledge to rate them with reasonable accuracy. 
Findings of the present study are likely to support this rationale. McDade-Montez et al. 
(2008) reported that suicidality was perceived as the most difficult to rate and wellbeing 
moderately difficult whereas the current study observed the highest agreement on items 
assessing suicidality and to some extent wellbeing. Moreover, a study by McAvay et al. 
(2005) also observed that the agreement was the highest for suicidal symptoms, slightly less 
so for psychological symptoms of depression, and the lowest for somatic symptoms. This 
may be especially so with suicidality, as it is possible that due to high saliency of these 
symptoms they are perceived as difficult to rate, while at the same time family informants are 
highly invested to identify them correctly. A recent study from the adult mental health 
literature found moderate to high agreements on suicide symptoms between adult psychiatric 
inpatients with depression and their family informants (DeJong & Overholser, 2009). This 
further suggests that family informants may be capable of providing useful information about 
??????????????????????? 
     In summary, even if present findings were somewhat unexpected it appears that they are to 
some extent consistent with findings from other studies in the mental health literature. 
However, it is important to note that overall kappa agreement between patient and informant 
on specific items was only slight to fair. In addition even on those few items where kappa 
agreement was moderate confidence intervals overlapped with other items on which 
agreement was fair or slight. Thus, it is questionable to what extent different levels of 
agreement on specific items are truly distinct and consequently to what extent that difference 
has any practical meaning.  
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4.4 Strengths and L imitations 
4.4.1 Strengths. 
     The present study has a number of important strengths. Firstly, it was conducted in a real-
????????????????????????????????????????????????????????????????????????????????????????????????
completion of HoNOS 65+). This allowed for an insight into practicality of using self-report 
measure in a psychogeriatric setting, which will be further discussed in the limitation section 
below.  
     Because of a fairly practical focus on the bigger project that the present study was part of, 
there was a strong commitment to include the majority of Ward K2 and MHC patients into 
the current investigation. Hence there were very few exclusion criteria and the research team 
put a lot of time and effort into obtaining self- and informant reports. This often involved 
several visits to the PMH regarding one patient and took a considerable amount of patience 
and persistence, as patients had several varying commitments as a part of their assessment 
and treatment at the hospital.  
     One of the other strengths of the present study was the oral form of administration of self-
report questionnaires, which although took a longer time than using written format, was more 
comprehensive and allowed to clarify any questions or difficulties that patients had during the 
interview.  
     Another valuable point of the present study is inclusion of the CUDOS as one of the main 
measures.  It is a relatively new instrument, and to the researcher?? knowledge it has not been 
used with an older population. Thus, the current study was the first attempt to explore its use 
with a geriatric population.  
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4.4.2 L imitations. 
     The present study also has some limitations worth acknowledging. One very apparent 
feature of the study was the low response rate. On the one hand, this could be acknowledged 
as a limitation of the study. However, this response rate in itself provides very interesting 
questions about the use of such measures and/or the feasibility of conducting this type of 
research in these settings. It was noted that the response rate for self-report was very poor on 
the inpatient ward as compared to the day-hospital. The Ward K2 patients were observed to 
be more unwell and distressed than the MHC patients. This could have had a negative impact 
on their ability to contemplate research participation or even fully comprehend an informed 
consent form. It was observed that several Ward K2 patients struggled with understanding the 
consent form and required greater assistance in completing it, through such means as using 
repetition or simpler language. In general, this was not the case at the MHC, and thus, it is not 
clear to what extend the low response rate at Ward K2 was negatively affected by the 
obligation to sign the consent form. It is possible that the response rate could have been 
higher if completing a self-report was a part of routine treatment planning.  
     Additionally, it was clearly observed that administration of self-report was often twice as 
long at the inpatient ward than at the day-hospital. There were several instances at Ward K2 
where administration took over an hour, whereas there were no such instances at MHC. It 
was noted that prolonged administration time was often due to psychological distress 
observed among Ward K2 patients, and in consequence, somewhat reduced cognitive 
capacity to entirely focus on research questions for a distinct period of time. The Ward K2 
patients were often very preoccupied with their admission and its impact on them and their 
families. There were several instances when patients could not focus their attention beyond 
intense rumination, anxious thoughts or delusions.  
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     Obtaining self-report from older individuals can be valuable for a variety of reasons 
discussed previously. However, considering the low response rate and prolonged 
administration time it would be important to further investigate either possible ways of 
administering a self-report in as unthreatening and unburdesome way as possible, or to look 
at the overall feasibility of using self report in psychogeriatric inpatient settings.   
     It is also important to note that even for those patients who filled in the self-report in either 
setting, only a minority had informant questionnaires successfully collected. There were 
variety of reasons that this may have occurred, such as the patients not having anyone who 
they had regular and frequent contact with, or the patient feeling as a burden to their family 
and not wanting to further inconvenience them. The low response rate among informants puts 
in question the practicability of using informant data routinely in a clinical setting. Future 
research could further address this issue.   
 
4.3 Implications of the Present Study 
     Implications of the present study are relevant to both clinical practice and research. First 
of all, the current study further confirms that clinicians should be cognizant of the fact that 
elderly patients and their family reports of depressive symptoms will differ to a considerable 
degree. ????????????? ???????????? ???m to have a tendency to report more depressive 
symptoms than patients. It is impossible to determine the reasons behind this from the present 
???????? ?????????? ????????????? ??? ?????? ???????? ???? ????? ???? ?????????? ???-off scores for 
patients and their informants. An awareness of this phenomenon can also help clinicians 
make sense of differences between patient and family reports of depressive symptoms.   
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     The GDS-15 is considered the gold standard in the assessment of geriatric depression. 
However, discrepancy between patients and informant reports of depressive symptoms was 
greater when the GDS-15 was used. Importantly, there were several reservations noted 
around its validity. It appears that caution should be exercised when using the GDS-15 in 
both clinical practice and research. On the other hand, the CUDOS appears to be a useful 
measure, and more research into its use with this population is warranted.  
     It is likely that the differences between patient and family reports of depressive symptoms 
might be greater for male than for female elderly patients. There seems to be no simple 
explanation for these gender differences. Thus, it appears that clinicians confronted with them 
should carefully explore them on a case-by-case basis. 
     Further, family members may be a valuable source of information regarding older 
????????? suicide risk.  They could potentially aid the risk assessment as they appear to be 
???????????????????????????????????????????????????????????????????????????????????????????????
It also appears that family and patient reports of somatic symptoms may be considerably 
different. As in the present study there was no gold standard, it is impossible to determine 
whose reports are closer to objective reality. A comparison of patient and family reports with 
an external measure of physical symptoms occurrence could assist in explaining these 
differences.  
          Interestingly, one of the observations while conducting the present study was that the 
feasibility of standard use of self-report questionnaires in assessment of psychogeriatric 
inpatients might be questionable. However, it should be further explored in future research. 
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4.5 Future Research 
     There are a few potential directions for future research that have been implicated through 
the findings of the present study. There appear to be gender differences in self-reported 
depressive symptomatology that increase discrepancy between self- and informant reports of 
these symptoms. Exploring the nature of these differences could improve diagnosis and 
treatment of depression in late life.  
     As previously mentioned, it would also be of interest to explore validity of the GDS-15. 
Although the GDS-15 has been designed to be specifically used with older people, its 
simplistic format, exclusion of depressed mood, suicidality, and somatic symptoms of 
depression as well as somewhat vaguely phrased questions, makes the exact nature of the 
construct being assessed questionable.  
     Examining further the rates of agreement between patient and family informant reports of 
specific depressive symptoms could have some interesting future implications. At present not 
many studies looked at this and findings of those that have are to some extent mixed. Family 
members are routinely involved in assessment and treatment of older individuals with mental 
health difficulties. Having a better understanding of how accurate they are in reporting 
specific symptoms of depression could assist clinicians in interpretation of common 
discrepancies between patient and family reports of these symptoms.  
     The use of informants may be of most use when the individual is unable or unwilling to 
complete a self-report. However, the present study does not necessarily indicate how closely 
this report would relate to the individuals report in these situations. Snow et al. (Snow, Cook, 
et al., 2005) defined and described two categories of externally rated data; proxy data and 
other-rated data. Proxy data referred to those collected from someone who speaks for a 
patient who cannot, will not, or is unavailable to speak for him or herself. The term other-
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rated data referred to situations in which the researcher collects ratings from a person other 
than the patient to gain multiple perspectives on the assessed constructs. The authors 
proposed that these two types of data differ in the way the measurement model is defined, the 
definition of a gold standard against which the measurements are validated, the analysis 
strategies appropriately used, and how the analyses are interpreted. The method in which data 
was analysed and interpreted in the present study was consistent with other-rated data. The 
validity of proxy data is a gap that would benefit from future research. In terms of research 
that deals with external raters of older individuals with mental health difficulties, it would be 
prudent to clearly define whether a study will be dealing with proxy or other-rated data. To 
be able to make that choice in an informed way, a population of interest should be assessed in 
terms of their capacity to complete self-report prior to data collection. 
     As previously noted it would be interesting to investigate the practicality of using 
informant data routinely in psychogeriatric setting. Reasons behind low informant response 
rates could be examined in more detail, and ways to improve it could be explored in order to 
incorporate significant others perspective in a systematic and cost/time effective way.  
     Finally, it appears to be vital to further examine the feasibility of the use of self-report 
scales in the inpatient psychogeriatric setting. Future studies could possibly look at such 
factors as length of time that it take to administer self-report and how  it may translate to the 
potential cost, impact of self-report on older individuals levels of distress, or accuracy of self 
reports. This could help to determine whether it is clinically practical as well as valid in terms 
of research to utilize self-report with older psychiatric inpatients.  
 
 
     
  
78 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     
  
79 
R E F E R E N C ES 
Aben, I., Verhey, F., Strik, J., Lousberg, R., Lodder, J., & Honig, A. (2003). A comparative 
study into the one year cumulative incidence of depression after stroke and 
myocardial infarction. Journal of Neurology, Neurosurgery, and Psychiatry, 74, 581-
585. 
Adams, K., & Moon, H. (2009). Subthreshold depression: characteristics and risk factors 
among vulnerable elders. Ageing & Mental Health, 13(5), 682-692. 
Alexopoulos, G. S., Meyers, B. S., Young, R. C., Mattis, S., & Kakuma, T. (1993). The 
course of geriat???? ??????????? ????? ???????????? ??????????? ?? ??????????? ???????
American Journal of Psychiatry, 150, 1693-1699. 
American Psychiatric Association. (2000). Diagnostic and Statistical Manual of Mental 
Disorders (4th ed., Text Revision). Washington, DC: Author. 
Arean, P., Uncapher, H., & Satre, D. (1998). Depression. In M. Hersen, & V. van Hasselt 
(Eds.), Handbook of clinical geropsychology (pp. 195-216). NY: Plenum Press.  
Ballard, C., Bannister, C., & Oyebode, F. (1996). Depresson in dementia sufferers. 
International Journal of Geriatric Psychiatry, 53, 305-312.  
Bartels, S. J., Horn, S. D., & Smout, R. J. (2003). Agitation and depression in frail nursing 
home elderly patients with dementia: treatment characteristics and service use. 
American Journal of Geriatric Psychiatry, 11, 231-238.  
Bassett, S. S., Magaziner, J., & Hebel, J. R. (1990). Reliability of proxy response on mental 
health indices for aged, community-dwelling women. Psychology and Ageing, 5(1), 
127-132. 
Beekman, A., Deeg, D., Braam, A., Smit, J., & Van Tilburg, W. (1997). Consequences of 
major and minor depression in later life: A study of disability, well-being and service 
utilization. Psychological Medicine, 27, 1397-1409.  
     
  
80 
Benek-Higgins, M., McReynolds, C. J., Hogan, E., & Savickas, S. (2008). Depression and the 
elder person: the enigma of misconceptions, stigma, and treatment. Journal of Mental 
Health Counselling, 30, 283-296.  
Blair-West, G. W., Cantor, C. H., Mellsop, G. W., & Eyeson-Annan, M. L. (1999). Life-time 
suicide risk in major depression: sex and age determinants. Journal of Affective 
Disorders, 55(2), 171-178.  
Blazer, D.G. (1994). Epidemiology of late-life depression. In L. Schneider, C. Reynolds, III, 
B. Lebowitz & A. Friedhoff  (Eds.), Diagnosis and Treatment of Depression in Late 
Life: Results of the NIH Consensus Development Conference (pp. 9?19). Washington 
DC: American Psychiatric Press.  
Blazer, D.G. (1999). Depression. In W.R. Hazzard, J.P. Blass, W.H. Ettinger, Jr. et al. (Eds.), 
Principles of geriatric medicine and gerontology  (4th ed.) (pp. 1331?1339). NY: 
McGraw-Hill.  
Blazer, D.G. (2003). Depression in late life: Review and commentary. Journals of 
Gerontology Series A-Biological Sciences and Medical Sciences, 58(3), 249?265. 
Braam, A., Beekman, A., Dewey, M., Delespaul, P., Fichter, M., Lobo, A., et al. (2010). 
Depression and Parkinsonism in older Europeans: results from the EURODEP 
concerted action. International Journal of Geriatric Society, 25(7), 679-687. 
Brodaty, H., Cullen, B., Thompson, C., Mitchell, P., Parker, G., Wilhelm, K., et al. (2005). 
Age and gender in the phenomenology of depression. American Journal of Geriatric 
Psychiatry, 13, 589-596.  
Brown, L. & Shinka, J. (2005). Development and initial validation of a 15-item informant 
version of the Geriatric Depression Scale. International Journal of Geriatric 
Psychiatry, 20, 911-918. 
Browne Oakley, M. A., Wells, J. E., Scott, K. M. (eds). (2006). Te Rau Hinengaro: The New 
     
  
81 
Zealand Mental Health Survey. Wellington: Ministry of Health. 
Bruce, M. L. & McAvay, G. J. (1998). Epidemiology of psychiatric disorders in late life. 
Primary Psychiatry, 5, 59-65. 
Bruce, M. L., McAvay, G. J., Raue, P. J., Brown, E. L., Meyers, B. S., Keohane, D. J. et al. 
(2002). Major depression in elderly home health care patients. American Journal of 
Psychiatry, 159, 1367-1374. 
Bruce, M. L., Seeman, T. E., Merrill, S. S., & Blazer, D. G. (1994). The impact of depressive 
symptomatology on physical disability: MacArthur studies of successful ageing. 
American Journal of Public Health, 84(11), 1796-1799.  
Bruce, M. L., Ten Have, T. R., Reynolds, C. F., Katz, I. I. Schulberg, K. C., Mulsant, B. H., 
et al. (2004). Reducing suicidal ideation and depressive symptoms in depressed older 
primary care patients. A randomized controlled trial. Journal of the American Medical 
Society, 291, 1081-1091.   
Burke, W., Rangwani, S., Roccaforte, W., Wengel, S. & Conley, D. (1997). The reliability 
and validity of the collateral source version of the Geriatric Depression Rating Scale 
administered by telephone. International Journal of Geriatric Psychiatry, 12, 288-
294. 
Burke, W., Roccaforte, W., Wengel, S., McArthur-Miller, D., Folks, D. & Potter, J. (1998). 
Disagreement in the reporting of depressive symptoms between patients with 
dementia of the Alzheimer type and their collateral sources. American Journal of 
Geriatric Psychiatry, 6, 308-319. 
Burns, A., Beevor, A., Lelliott, P., Wing, J., Blakey, A., Orrell, L., et al. (1999). Health of the 
Nation Outcome Scales for elderly people (HoNOS 65+). British Journal of 
Psychiatry, 174, 424-427. 
Burns, A., Lawlor, B., & Craig, S. (2004). Assessment scales in old age psychiatry (2nd ed.). 
     
  
82 
London: Martin Dunitz.  
Burrows, A., Satlin, A., Salzman, C., Nobel, K., & Lipsitz, L. A. (1995). Depression in a 
long-term care facility: Clinical features and discordance between nursing assessment 
and patient interviews. Journal of the American Geriatrics Society, 43(10), 1118-
1122. 
Burvill, P. (1994). The outcome of depressive illness in old age. In E. Chiu, D. Ames, & T. 
Arie (Eds.), Functional psychiatric disorders of the elderly (pp. 111-125). NY: 
Cambridge University Press.   
Cacchione, P., Powlishta, K., Grant, E., Buckles, V. & Morris, J. (2003). Accuracy of 
collateral source reports in very mild to mild dementia of the Alzheimer type. The 
American Geriatrics Society, 51, 819-823. 
Carter, J. D., Frampton, C. M., Mulder, R. T., Luty, S. E., & Joyce, P. R. (2010). The 
relationship of demographic, clinical, cognitive and personality variables to the 
discrepancy between self- and clinician rated depression. Journal of Affective 
Disorders, 124, 202-206. 
Castilla-Puentes, R., & Habeych, M. (2010). Subtypes of depression among patients with 
????????????????????????????????????????????????????????????????, 6(1), 63-69. 
Chopra, M.P., Zubritsky, C., Knott, K., Ten Have, T., Hadley, T., Coyne, J.C., et al. (2005). 
Importance of subsyndromal symptoms of depression in elderly patients. American 
Journal of Geriatric Psychiatry, 13(7), 597?606. 
Coe, G. (ed). (2003). The integrated continuum of care for older people health services. NZ: 
Canterbury District Health Board. 
Cohen, J. (1988). Statistical power analysis for the behavioural sciences (2nd ed.). New 
Jersey: Lawrence Erlbaum Associates Inc.  
Cullum, S., Tucker, S., Todd, C., & Brayne, C. (2006). Screening for depression in older 
     
  
83 
medical inpatients. International Journal of Geriatric Psychiatry, 21, 469-476.  
???????????????? ??????? ???????? ????????????????????????????????????????????????????????
diagnosis of major depression in aged-care settings. The American Journal of 
Geriatric Psychiatry, 17(5), 359-367. 
DeJong, T. M., & Overholser, J. C. (2009). Assessment of depression and suicidal actions: 
agreement between suicide attempters and informant reports. Suicide and Life-
Threatening Behaviour, 39(1), 38-46. 
Dorenlot, P., Harboun, M., Bige, V., Henrard, J., & Ankiri, J. (2005). Major depression as a 
risk factor for early institutionalization of dementia patients living in the community. 
International Journal of Geriatric Psychiatry, 20, 471-478. 
Edelstein, B. A., Kalish, K. D., Drozdick, L. W., & McKee, D. R. (1999). Assessment of 
depression  and bereavement in older adults. In P. Lichtenberg (Ed.), Handbook of 
assessment in clinical gerontology (pp. 11-58). NY: Wiley & Sons.  
Edelstein, B. A., Northrop, L. E., & MacDonald, L. M. (2009). Assessment. In E. Rosowsky, 
Casciani, J., & Merla, A. (Eds.), Geropsychology and long term care (pp. 23-48). NY: 
Springer. 
Fairchild, K., & Scogin, F. (2008). Assessment and treatment of depression. In K. Laidlaw, & 
Knight, B. (Eds.), Emotional disorders in later life (pp. 213-231). NY: Oxford 
University Press Inc.  
Fleiss, J., Cohen, J., & Everitt, B. (1969). Large sample errors for kappa and weighted kappa. 
Psychological Bulletin, 72, 323-327. 
Friedman, B., Marnin, J., & Delavan, R. (2005). Psychometric properties of the GDS-15. 
Journal of American Geriatrics Society, 53, 1570-1576. 
Gee, S., Croucher, M., & Beveridge, J. (2010). Measuring outcomes in mental health services 
for older people: an evaluation of the Health of the Nation Outcome Scales for elderly 
     
  
84 
people (HoNOS 65+). International Journal of Disability, Development and 
Education, 57, 155-174.  
Jorm, A. F. (2001). History of depression as a risk factor for dementia: an update review. 
Australian and New Zealand Journal of Psychiatry, 135, 776-781. 
Kane, R., Ouslander, J., & Abrass, I. (2004). Diagnosis and management of depression. In 
Essentials of clinical geriatrics (5th ed.) (pp. 147-171). USA: The McGraw-Hill 
Companies, Inc.  
Katon, W. J., Lin, E., Russo, J., & Unutzer, J. (2003). Increased medical costs of a 
population-based sample of depressed elderly patients. Archives of Geriatric 
Psychiatry, 60(9), 897-903.   
Katona, C. (2000). Managing depression and anxiety in the elderly patient. European 
Neuropsychopharmacology, 10, S427-S432.  
Keiffer, K., & Reeses, R. (2002). A reliability generalization study of the Geriatric 
Depression Scale. Education and Psychological Measurement, 62, 969-994. 
Klerman, G. L. (1989). Efficacy of a brief psychosocial interventions for symptoms of stress 
and distress in primary care. Medical Care, 25(11), 1078-1088. 
Knauper, B. & Wittchen, H. U. (1994). Diagnosing major depression in the elderly: evidence 
for response bias in standardized interviews? Journal of Psychiatric Research, 28, 
147-164. 
Koenig, H. (1997). Differences in psychosocial and health correlates of major and minor 
depression in medically ill older adults. Journal of American Geriatrics Society, 45, 
1487-1495. 
Lamar, M., Charlton, R., Morris, R., & Marcus, H. (2010). The impact of subcortical white 
matter disease on mood in euthymic older adults: a diffusion tensor imaging study. 
The American Journal of Geriatric Psychiatry, 18(7), 634-641. 
     
  
85 
Lamberty, G. L., & Bieliauskas, L. A. (1993). Distinguishing between depression and 
dementia in the elderly: a review of neuropsychological findings. Archives of Clinical 
Neuropsychology, 8, 149-170. 
Landis, J. & Koch, G. (1977). The measurement of observer agreement for categorical data. 
Biometrics, 33, 159-174. 
Lawrence, J., Davidoff, D., & Berlow, Y. (2003). Diagnosing depression in later life. In J. E. 
Ellison & S. K. Verma (Eds.), Depression in later life: a multidisciplinary psychiatric 
approach (pp. 55-79). NY: Marcel Dekker, Inc.  
Lewis, S., Hinchcliffe, K., Katona, C., & Livingstone, G. (1998). An informant interview for 
the diagnosis of dementia and depression in older adults (IDD-GMS). International 
Journal of Geriatric Psychiatry, 13, 298-309. 
Lebowitz, B., Pearson, J., Schneider, L., et al. (1997). Diagnosis and treatment of depression 
late in life. The Journal of the American Medical Association , 278, 1186-1190.  
Li, W. & Yeates, C. (2007). Mental health status of home care elders in Michigan. The 
Gerontologist, 47 (4), 528-534. 
Livingston, G., Thomas, A., Graham, N., Blizard, R., & Mann, A. (1990). The Gospel Oak 
Project: the use of health and social services by dependent elderly people in the 
community. Health Trends, 2, 70-73.  
Logsdon, R. G., Gibbons, L. E., McCurry, S. M., & Teri, M. (2002). Assessing quality of life 
in older adults with cognitive impairment. Psychosomatic Medicine, 64, 510-519.  
Lyness, J. M., Bruce, M. L., Koenig, H. G., Parmelee, P.A., Schultz, R., Lawton, M. P., & 
Reynolds, C. F. (1996). Depression and medical illness in late life: report of a 
symposium. Journal of American Geriatrics Society, 44, 198-203.  
Lyness, J. M., Cox, C., Curry, J., Conwell, Y., King, D. A., & Caine, E. D. (1995). Older age 
and the underreporting of depressive symptoms. Journal of the American Geriatrics 
     
  
86 
Society, 43(3), 216-221.  
Magaziner, J., Zimmerman, S. I., Gruber-Baldini, A. L., Hebel, J. R., & Fox, K. M. (1997). 
Proxy reporting in five areas of functioning status. Comparison with self-reports and 
observations of performance. American Journal of Epidemiology, 146(5), 418-428. 
Mattisson, C., Bogren, M., Horstmann, V., Munk-Jorgensen, P., & Nettelbladt, P. (2007). 
The long-term course of depressive disorders in the Lundby Study. Psychological 
Medicine, 37, 883-891. 
McAvy, G., Bruce, M., Raue, P. & Brown, E. (2004). Depression in elderly homecare 
patients: patients versus informant reports. Psychological Medicine, 34, 1507-1517. 
McAvy, G., Raue, P., Brown, E. & Bruce, M. (2005). Symptoms of depression in older 
home-care patients: Patient and informant reports. Psychology and Ageing, 20, 507-
518. 
McDade-???????????? ??????????????????? ??????????????????????????????????????????????
visibility on informant reporting. Psychology and Ageing, 23, 940-946. 
Neumann, P. J., Araki, S. S., & Gutterman, E. M. (2000). The use of proxy respondents in 
studies of older adults: lessons, challenges, and opportunities. Journal of the 
American Geriatrics Society, 48, 1646-1654.  
Nitcher, R., Bourke, W., Roccaforte, W. & Wengel, S. (1993). A collateral source of the 
Geriatric Depression Rating Scale. The American Journal of Geriatric Psychiatry, 1, 
143-152. 
Nordhus, I. H. (2008). Manifestations of depression and anxiety in older adults. In B. Woods 
& L. Clare (Eds.), Handbook of the Clinical Psychology of Ageing (2nd ed.) (pp. 97-
111). UK: John Wiley and Sons, Ltd. 
Nyunt, M., Fones, C., Niti, M., & Ng, T. (2009). Criterion-based reliability and validity of the 
Geriatric Depression Screening Scale (GDS-15) in a large validation sample of 
     
  
87 
community-living Asian older adults. Aging & Mental Health, 13, 376-382. 
Okonkwo, O., Wadley, W., Griffith, H., Belue, K., Lanza, S., Zamrini, E., et al. (2008). 
Awerness of deficits of financial abilities in patients with mild cognitive impairment: 
going beyond self-informant discrepancy. The American Journal of Geriatric 
Psychiatry, 16, 650-659. 
Olin, J., Schneider, L., Eaton, E., Zemansky, M., & Pollock, V. (1992). The Geriatric 
Depression Scale and Beck Depression Inventory as screening instruments in an older 
adult outpatient population. Psychological Assessment, 4, 190-192.  
Parmelee, P. & Katz, I. (1990). Geriatric Depression Scale. Journal of the American 
Geriatrics Society, 38, 1379.  
Perkins, E. A. (2007). Self- and proxy reports across three populations: older adults, persons 
??????????????????????????????????????????????????????????????????????Journal of Policy 
and Practice in Intellectual Disabilities, 4(1), 1-10. 
Reynolds, C.F., Frank, E., Dew, M.A., Houck, P. R., Miller, M., Mazumdar, S., et al. (1999). 
Treatment of 70+ -year-old with recurrent major depression. The American Journal of 
Geriatric Psychiatry, 7, 64?9. 
Rosenberg, P. B., Mielke, M. M., & Lyketsos, C. G. (2005). Caregiver assessment of 
??????????????????????????????????????????????????dinal analysis in a drug treatment 
study. The American Journal of Geriatric Psychiatry, 13(9), 822-826.  
Ross, G. W., Abbott, R. D., Petrovitch, H., Masaki, K. H., Murdaugh, C., Trockman, J. D. et 
al. (1997). Frequency and characteristics of silent dementia among elderly Japanese-
American men: the Honolulu-Asia aging study. Journal of the American Medical 
Association, 277(10), 800-805.    
Rubin, E., Veiel, L., Kinscherf, D., Morris, J. & Storandt, M. (2001). Clinically significant 
depressive symptoms and very mild to mild dementia of the Alzheimer type. 
     
  
88 
International Journal of Geriatric Psychiatry, 16, 694-701. 
Seitz, D., Purandare, N., & Conn, D. (2010). Prevalence of psychiatric disorders among older 
adults in long-term care homes: a systematic review. International Psychogeriatrics, 
22(7), 1025-1039. 
Sheikh, J. L. & Yesavage, J. A. (1986). Geriatric Depression Scale (GDS). Recent evidence 
and development of a shorter version. In T.L. Brink (Ed.), Clinical Gerontology: A 
Guide to Assessment and Intervention (pp. 165-173). NY: The Haworth Press, Inc. 
Smalbrugge, M., Jongenelis, L., Pot, A. M., Beekman, A. T., & Eefsting, J. (2008). Screening 
for depression and assessing change in severity of depression. Is the Geriatric 
Depression Scale (30-, 15-, and 8-item versions) useful for both purposes in nursing 
home patients? Aging & Mental Health, 12(2), 244-248. 
Snow, A. L., Cook, K. F., Lin, P., Morgan, R. O., & Magaziner, J. (2005). Proxies and other 
external raters: methodological considerations. Health Services Research, 40(5), 
1676-1692.   
Snow, A. L., Kunik, M. E., Molinari, V. E., Orengo, C. A., Doody, R., Graham, D. P., et al. 
(2005). Accuracy of self-reported depression in persons with dementia. Journal of the 
American Geriatric Society, 53, 389-396.  
Steffens, D., Scoog, I., Norton, M., Hart, A., Tshanz, J., Plassman, B., et al. (2000). 
Prevalence of depression and its treatment in the elderly population: the Cache 
County study. Archives of General Psychiatry, 57(6), 601-607.  
Unutzer, J., Katon, W., Sullivan, M., & Miranda, J. (1999). Treating depressed older adults in 
primary care: Narrowing the gap between efficacy and effectiveness. Milbank 
Quarterly, 77(2), 225-256.  
Unutzer, J., Patrick, D. L., Simon, G., Grembowski, D., Walker, E., Rutter, C., et al. (1997). 
Depressive symptoms and the cost of health services in HMO patients aged 65 years 
     
  
89 
and older. The Journal of the American Medical Association, 227(20), 1618-1623.  
Walker, E. M., & Steffens, D. C. (2010). Understanding depression and cognitive impairment 
in the elderly. Psychiatric Annals, 40(1), 29-40.  
Watson, L. C., & Pignone, M. P. (2003). Screening accuracy for late-life depression in 
primary care: A systematic review. The Journal of Family Practice, 52(12), 956-964. 
Woods, B. (2008). Assessing mood, wellbeing and quality of life. (2008). In B. Woods and L. 
Clare (Eds.), Handbook of the Clinical Psychology of Ageing (2nd ed.) (pp. 415?427). 
London: John Wiley & Sons, Ltd.  
Yesavage, J., Brink, T., Rose, T., Lum, O., Huang, V., Adey, M., et al. (1983). Development 
and validation of geriatric screening scale: a preliminary report. Journal of 
Psychiatric Research, 17, 37-49. 
Zabora, J., Brintzenhofeszoc, K., Curbow, B., Hooker, C., & Piantadosi, S. (2001). The 
prevalence of psychological distress by cancer site. Psycho-Oncology, 10, 19-28. 
Zimmerman, M., Chelminsky, I., McGlinchey, J., & Posternak, M. (2008). A clinically useful 
depression outcome scale. Comprehensive Psychiatry, 49, 131-141.  
Zimmerman, M., McGlinchey, J., & Chelminsky, I. (2008). An inadequate community 
standard of care: lack of measurement of outcome when treating depression in clinical 
practice. Primary Psychiatry, 16 (6), 67-75. 
Zisook, S., & Downs, N. S. (1998). Diagnosis and treatment of depression in late life. 
Journal of Clinical Psychiatry, 59, 80-91.  
 
 
 
 
     
  
90 
APPE NDI X A 
G L OSSA R Y O F M E DI C A L T E R MS 
 
???????????? ???????? ???? - is the most common form of dementia; it is an incurable, 
degenerative, and terminal disease. Most often, it is diagnosed in people over 65 years 
of age, although the less-prevalent early-?????????????????? ???? ??????????? ?????????
Although the course of Alzheimer's disease is unique for every individual, there are 
many common symptoms.  The earliest observable symptoms are often mistakenly 
thought to be 'age-related' concerns, or manifestations of stress. In the early stages, the 
most commonly recognized symptom is inability to acquire new memories, such as 
difficulty in recalling recently observed facts. As the disease advances, symptoms 
include confusion, irritability and aggression, mood swings, language breakdown, 
long-term memory loss, and the general withdrawal of the sufferer as their senses 
decline. Gradually, bodily functions are lost, ultimately leading to death. Individual 
prognosis is difficult to assess, as the duration of the disease varies. AD develops for 
an indeterminate period of time before becoming fully apparent, and it can progress 
undiagnosed for years. The mean life expectancy following diagnosis is 
approximately seven years.  
Haematoma - is an extravasation of blood outside the blood vessels, generally the result of 
hemorrhage. A hematoma is a pocket or localized collection of blood usually in liquid 
form within the tissue.  
Hyperparathyroidism - is overactivity of the parathyroid glands resulting in excess production 
of parathyroid hormone (PTH). The parathyroid hormone regulates calcium and 
phosphate levels and helps to maintain these levels. Excessive PTH secretion may be 
due to problems in the glands themselves, in which case it is referred to as primary 
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hyperparathryroidism and which leads to hypercalcemia (raised calcium levels). It 
may also occur in response to low calcium levels, as encountered in various situations 
such as vitamin D deficiency or chronic kidney disease; this is referred to as 
secondary hyperparathyroidism. In all cases, the raised PTH levels are harmful to 
bone, and treatment is often needed.  
Hypothyroidism - is a deficiency of thyroid hormone. Iodine deficiency is the most common 
cause of hypothyroidism worldwide but it can be caused by any number of other 
causes such as several conditions of the thyroid gland, or less commonly, the pituitary 
gland or hypothalamus. Early hypothyroidism has often very mild and unspecific 
symptoms. Hypothyroidism can be associated with the following symptoms; poor 
muscle tone, fatigue, any form of menstrual irregularity and fertility problems, 
elevated serum cholesterol, cold intolerance, increased sensitivity to cold, 
constipation, depression, muscle cramps, joint pains, dry and  itchy skin, weight gain, 
and others.  
Myocardial Infarction - commonly known as a heart attack, is the interruption of blood 
supply to a part of the heart, causing heart cells to die. This is most commonly due to 
occlusion (blockage) of a coronary artery following the rupture of a vulnerable 
atherosclerotic plaque which is an unstable collection of lipids and white blood cells 
in the wall of an artery. The resulting ischemia (restriction in blood supply) and 
oxygen shortage, if left untreated for a sufficient period of time, can cause damage or 
death (infarction) of heart muscle tissue (myocardium). 
Pancreatic Cancer - is a malignant neoplasm of the pancreas. It is estimated that in 2010 more 
than 43,000 individuals in the United States have been diagnosed with this condition, 
and 36,800 have died from the disease. The prognosis is poor, with fewer than 5% of 
those diagnosed still alive five years after diagnosis. Complete remission is still rare. 
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???????????? ???????? ???? - is a progressive degenerative disorder of the central nervous 
system. Early in the course of the disease, the most obvious symptoms are movement-
related, including shaking, rigidity, slowness of movement, and difficulty with 
walking and gait. Later, cognitive and behavioral problems may arise, with dementia 
commonly occurring in the advanced stages of the disease. Other symptoms include 
sensory, sleep and emotional problems. PD typically becomes apparent around the 
age of 60 years and is unusual before the age of 40 years. 
Vascular Dementia - is the second most common form of dementia after (AD) in older adults; 
is thought to be an irreversible form of dementia, and its onset is caused by a number 
of small strokes or sometimes, one large stroke. The term refers to a group of 
syndromes caused by different mechanisms all resulting in vascular lesions in the 
brain. Early detection and accurate diagnosis are important, as vascular dementia is at 
least partially preventable. 
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APPE NDI X B 
????????????????????????????????? 
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APPE NDI X C 
G E RI A T RI C D EPR ESSI O N SC A L E 15-I T E M V E RSI O N (G DS-15) 
 
M O O D SC A L E 
Choose the best answer for how you have felt over the past week: 
 
??????????????????????????????????????????????? ?????????????? YES / NO 
???????????????????? ?????????????????????????????????????? ??????? YES / NO 
???????????????????????????????????????? ?????????????????? YES / NO  
4. Do you often get bored?  ?????????????????????YES / NO 
??????????????????????????? ????????????????? ?????????????? YES / NO 
???????????????????????????????????????????????????????????????? ?????? YES / NO 
????????????????????? ????????????????? ????????????????? YES / NO 
??????????????????????????????? ????????????????????? YES / NO 
9. Do you prefer to stay at home, rather than going out and doing new things? ???YES / NO 
????????????????????????? ?????????????????? ??????????? ????? ????? YES / NO 
11. ?????????????????????????????????????????????? ???????????? YES / NO 
?????????????????????????????????????????????????????? ????????? YES / NO 
???????????????????????????????? ????????????????????? YES / NO 
14. Do you feel that your situation is hopeless? ????????????? YES / NO 
?????????????????????? ???????????????????????????????????????? ?????? YES / NO 
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APPE NDI X D 
IN F O R M A N T V E RSI O N O F T H E G DS-15 
 
M O O D SC A L E 
 
Choose the best answer for how _____________ has felt over the past week: 
 
1. Are they ????????????????????????????????????? ????????????? YES / NO 
????????????????????? ??????????????????????????????????????? ?????? ???YES / NO 
?????????????????????????????????????????? ????????????????? YES / NO  
4. Do they often get bored?  ???????????????????? YES / NO 
???????????????????????????? ????????????????? ????????????? YES / NO 
?????????????????????????????????????????????????????????????????? ????? YES / NO 
?????????????????????? ????????????????? ????????????????? YES / NO 
8. Do they often ??????????????? ????????????????????? YES / NO 
9. Do they prefer to stay at home, rather than going out and doing new things?  ????YES / NO 
??????????????????????????? ?????????????????? ??????????? ????? ???? YES / NO 
11. Do they think it is wonderful to ?????????????? ??????????? YES / NO 
???????????????????????????????????????????????????????? ???????? YES / NO 
????????????????????????????????? ???????????????????? YES / NO 
??????????????????????????????????????????????????? ???????????? YES / NO 
15. Do ???????????????? ????????????????????????????????????????? ?????? YES / NO 
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APPE NDI X E 
C L INI C A L L Y USE F U L D EPR ESSI O N O U T C O M E SC A L E (C UD OS) 
 
Instructions 
This questionnaire includes questions about symptoms of depression. For each item, please 
indicate how well it describes you during the past week, including today. Circle the number 
in the columns next to the item that best describes you. 
Rating Guidelines 
0=not at all true (0 days) 
1=rarely true (1?2 days) 
2=sometimes true (3?4 days) 
3=often true (5?6 days) 
4=almost always true (every day) 
During the ??????????????????????????? 
 
????????????????????????????? ??????????????????? 0   1   2   3   4 
?????????????????????????????? ???????????????????? ????????? 0   1   2   3   4 
3. My appetite was poor, and ??????????????????????????? ?????? 0   1   2   3   4 
??? ??????????????? ???????????????????????? ?????????? 0   1   2   3   4 
?????????????????????????????? ??????????????????? 0   1   2   3   4 
?????????????????????? ????? ????????????????? 0   1   2   3   4 
???????????????????????? ????????????????????????????????? ?????????? 0   1   2   3   4 
??????????????????????????????????????? ???????????????????? ???? ?? 0   1   2   3   4 
??? ???????????????????????? ????????????????? 0   1   2   3   4 
10. I felt ???????? ????????????????????????0   1   2   3   4 
??????????????????????????????? ??????????????????? 0   1   2   3   4 
?????????????????????????????????? ??????????????? 0   1   2   3   4 
?????????? ????????????????? ???????????????????????????? ????? 0   1   2   3   4 
????????????????????????? ???????????????????? 0   1   2   3   4 
???????????????????????????? ??????? ???????????????? 0   1   2   3   4 
??????????????????????????????????????????????? ?????????? 0   1   2   3   4 
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17. Overall, how much have symptoms of depression interfered with or caused difficulties in 
your life during the past week? 
0) not at all 
1) a little bit 
2) a moderate amount 
3) quite a bit 
4) extremely 
 
18. How would you rate your overall quality of life during the past week? 
0) very good; my life could hardly be better 
1) pretty good; most things are going well 
2) the good and bad parts are about equal 
3) pretty bad; most things are going poorly 
4) very bad; my life could hardly be worse 
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APPE NDI X F 
IN F O R M A N T V E RSI O N O F T H E C UD OS (C UD OS-I) 
 
Instructions 
This questionnaire includes questions about symptoms of depression. For each item, please 
indicate how well it describes ______________during the past week, including today. Circle 
the number in the columns next to the item that best describes them. 
Rating Guidelines 
0=not at all true (0 days) 
1=rarely true (1?2 days) 
2=sometimes true (3?4 days) 
3=often true (5?6 days) 
4=almost always true (every day) 
During the ??????????????????????????? 
1. They ???????????????????????? ????????????????? 0   1   2   3   4 
?????????????????????????????????????????????????????????? ?????? 0   1   2   3   4 
?????????????????????????????????????????????????????????????? ??? 0   1   2   3   4 
4. Their appetite was much ???????????????????? ??????.?? 0   1   2   3   4 
????????????????????????????????? ????????????????? 0   1   2   3   4 
?????????????????????????? ????? ?????????????? 0   1   2   3   4 
??????????????????????????? ????????????????????????????????? ???????? 0   1   2   3   4 
8. They felt physically slowed down, like their body was stuck in mud. 0   1   2   3   4 
??????????????????????????????? ???????????????? 0   1   2   3   4 
?????????????????????? ?????????????????????? 0   1   2   3   4 
11. They thought ????????????????????? ??????????????? 0   1   2   3   4 
????????????????????????????????????? ????????????? 0   1   2   3   4 
????????????? ????????????????? ???????????????????????????? ??? 0   1   2   3   4 
???????????????????????????????? ??????????????.. 0   1   2   3   4 
??????????????????????????????????????????? ???????????? 0   1   2   3   4 
?????????????????????????????????????????????????? ???????? 0   1   2   3   4 
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17. Overall, how much have symptoms of depression interfered with or caused difficulties in 
their life during the past week? 
0) not at all 
1) a little bit 
2) a moderate amount 
3) quite a bit 
4) extremely 
 
18. How would you rate their overall quality of life during the past week? 
0) very good; their life could hardly be better 
1) pretty good; most things are going well 
2) the good and bad parts are about equal 
3) pretty bad; most things are going poorly 
4) very bad; their life could hardly be worse 
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APPE NDI X G 
H E A L T H O F T H E N A T I O N O U T C O M E SC A L E 65+ (HoN OS 65+) 
 
General rating guidelines 
Note:  
Staff enter the ratings online onto the Canterbury District Health Board system. 
The HoNOS is a mandated assessment measure and will be rated regardless of participation 
in the research study 
? Perform a full clinical assessment of the patient's clinical history and current problems  
? Rate items in order from 1 to 12.  
? Do not include information already rated in an earlier item.  
? Rate the most severe problem that occurred in the period rated.  
? The rating period is generally the preceding two weeks for inpatients at admission, for 
hospital outpatients, and for all clients of community-based services. The exception is 
at discharge from acute inpatient care, in which case the rating period should 
generally be the preceding 72 hours.  
? Each item is rated on a 5-point scale of severity (0 to 4) as follows: 
0. No problem 
1. Minor problem requiring no formal action 
2. Mild problem. Should be recorded in a care plan or other case record 
3. Problem of moderate severity 
4. Severe to very severe problem 
7. Not known / Unable to rate.  
? Specific help for rating each point on each item is provided in the Glossary.   
? As far as possible, the use of rating point 7 should be avoided, because missing data 
make scores less comparable over time or between settings. 
HoNOS65+ scores: Clinical significance and recommended actions 
Not  clinically  
significant 
0  No problem  Problem not present.  
1  Minor problem  Requires no formal action. May or may not be recorded 
in clinical file.  
Clinically  
significant   
2  Mild problem  Warrants recording in clinical file. May or may not be 
incorporated in care plan. 
3  Moderate 
problem  
Warrants recording in clinical file. Should be 
incorporated in care plan.  
4  Severe to very 
severe problem  
Most severe category for patients with this problem. 
Warrants recording in clinical file. Should be 
incorporated in care plan. Note: Patient can get worse.  
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HoNOS65+ glossary 
1. Behavioural disturbance (eg. overactive, aggressive, disruptive or agitated behaviour , 
uncooperative or resistive behaviour) 
Include such behaviour due to any cause, eg. dementia, drugs, alcohol, psychosis, 
depression, etc. 
Do not include bizarre behaviour, rated at Scale 6. 
0. No problems of this kind during the period rated. 
1. Occasional irritability, quarrels, restlessness etc., but generally calm and co-operative and 
not requiring any specific action. 
2.  Includes aggressive gestures, pushing or pestering others; threats or verbal aggression; 
lesser damage to property (e.g. broken cup, window); significant overactivity or agitation; 
intermittent restlessness or wandering (day or night); uncooperative at times, requiring 
encouragement and persuasion. 
3.  Physically aggressive to others or animals (short of rating 4); more serious damage to, or 
destruction of, property; frequently threatening manner, more serious or persistent 
overactivity or agitation; frequent restlessness or wandering; significant problems with 
co-operation, largely resistant to help or assistance. 
4.  At least one serious physical attack on others (over and above rating of 3); major or 
persistent destructive activity (e.g. fire-setting); persistent and threatening behaviour; 
severe overactivity or agitation; sexually disinhibited or other inappropriate behaviour 
(e.g. deliberate inappropriate urination or defecation); virtually constant restlessness or 
wandering; severe problems related to non-compliant or resistive behaviour. 
 
2. Non-accidental self-injury 
Do not include accidental self-injury (due eg. to dementia or severe learning disability); any 
cognitive problem is rated at Scale 4 and the injury at Scale 5. 
Do not include illness or injury as a direct consequence of drug or alcohol use rated at Scale 
3, (eg. cirrhosis of the liver or injury resulting from drunk-driving are rated at Scale 5). 
0. No problem of this kind during the period rated. 
1.  Fleeting thoughts of self-harm or suicide; but little or no risk during the period rated. 
2.  Mild risk during period; includes more frequent thoughts or talking about self-harm or 
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suicide (including 'passive' ideas of self-harm such as not taking avoiding action in a 
potentially life-threatening situation, eg. while crossing a road). 
3.  
Moderate to serious risk of deliberate self-harm during the period rated; includes frequent 
or persistent thoughts or talking about self-harm; includes preparatory behaviours, eg. 
collecting tablets. 
4.  Suicidal attempt or deliberate self-injury during period. 
 
3. Problem drinking or drug-taking 
Do not include aggressive or destructive behaviour due to alcohol or drug use, rated at Scale 
1. 
Do not include physical illness or disability due to alcohol or drug use, rated at Scale 5. 
0. No problem of this kind during the period rated. 
1.  Some over-indulgence but within social norm. 
2.  Occasional loss of control of drinking or drug-taking; but not a serious problem. 
3.  Marked craving or dependence on alcohol or drug use with frequent loss of control, 
drunkenness, etc. 
4.  Major adverse consequences or incapacitated due to alcohol or drug problems. 
 
4. Cognitive problems 
Include problems of orientation, memory, and language associated with any disorder: 
dementia, learning disability, schizophrenia, etc.             
Do not include temporary problems (eg. hangovers) which are clearly associated with 
alcohol, drug or medication use, rated at Scale 3. 
0. No problem of this kind during the period rated. 
1.  Minor problems with orientation (eg. some difficulty with orientation to time) or memory 
(eg. a degree of forgetfulness but still able to learn new information), no apparent 
difficulties with the use of language. 
2.  Mild problems with orientation (eg. frequently disorientated to time) or memory (eg. 
definite problems learning new information such as names, recollection of recent events; 
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deficit interferes with everyday activities); difficulty finding way in new or unfamiliar 
surroundings; able to deal with simple verbal information but some difficulties with 
understanding or expression of more complex language. 
3.  Moderate problems with orientation (eg. usually disorientated to time, often place) or 
memory (eg. new material rapidly lost, only highly learned material retained, occasional 
failure to recognise familiar individuals); has lost the way in a familiar place; major 
difficulties with language (expressive or receptive). 
4.  Severe disorientation (eg. consistently disorientated to time and place, and sometimes to 
person) or memory impairment (eg. only fragments remain, loss of distant as well as 
recent information, unable to effectively learn any new information, consistently unable 
to recognise or to name close friends or relatives); no effective communication possible 
through language or inaccessible to speech. 
 
5. Physical illness or disability problems 
Include illness or disability from any cause that limits mobility, impairs sight or hearing, or 
otherwise interferes with personal functioning (eg. pain).  
Include side-effects from medication; effects of drug/alcohol use; physical disabilities 
resulting from accidents or self-harm associated with cognitive problems, drunk driving etc. 
Do not include mental or behavioural problems rated at Scale 4. 
0. No physical health, disability or mobility problems during the period rated. 
1.  Minor health problem during the period (e.g. cold); some impairment of sight or hearing 
(but still able to function effectively with the aid of glasses or hearing aid). 
2.  Physical health problem associated with mild restriction of activities or mobility (e.g. 
restricted walking distance, some degree of loss of independence); moderate impairment 
of sight or hearing (with functional impairment despite the appropriate use of glasses or 
hearing aid); some degree of risk of falling, but low and no episodes to date; problems 
associated with mild degree of pain. 
3.  Physical health problem associated with moderate restriction of activities or mobility (e.g. 
mobile only with an aid - stick or Zimmer frame - or with help); more severe impairment 
of sight or hearing (short of rating 4); significant risk of falling (one or more falls); 
problems associated with a moderate degree of pain. 
4.  Major physical health problem associated with severe restriction of activities or mobility 
(e.g. chair or bed bound); severe impairment of sight or hearing (e.g. registered blind or 
deaf); high risk of falling (one or more falls) because of physical illness or disability; 
     
  
105 
problems associated with severe pain; presence of impaired level of consciousness. 
 
6. Problems associated with hallucinations and delusions 
Include hallucinations and delusions (or false beliefs) irrespective of diagnosis. 
Include odd and bizarre behaviour associated with hallucinations or delusions (or false 
beliefs).                
Do not include aggressive, destructive or overactive behaviours attributed to hallucinations, 
delusions or false beliefs, rated at Scale 1. 
0. No evidence of delusions or hallucinations during the period rated. 
1.  Somewhat odd or eccentric beliefs not in keeping with cultural norms. 
2.  Delusions or hallucinations (eg. voices, visions) are present, but there is little distress to 
consumer or manifestation in bizarre behaviour, that is, a present, but mild clinical 
problem. 
3.  Marked preoccupation with delusions or hallucinations, causing significant distress or 
manifested in obviously bizarre behaviour, that is, moderately severe clinical problem. 
4.  Mental state and behaviour is seriously and adversely affected by delusions or 
hallucinations, with a major impact on consumer or others. 
 
7. Problems with depressive symptoms 
Do not include overactivity or agitation, rated at Scale 1. 
Do not include suicidal ideation or attempts, rated at Scale 2. 
Do not include delusions or hallucinations, rated at Scale 6.  
Rate associated problems (eg. changes in sleep, appetite or weight; anxiety symptoms) at 
Scale 8. 
0. No problems associated with depression during the period rated. 
1.  Gloomy; or minor changes in mood only. 
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2.  Mild but definite depression on subjective or objective measures (eg. loss of interest or 
pleasure, lack of energy, loss of self-esteem, feelings of guilt). 
3.  Moderate depression on subjective or objective measures (depressive symptoms more 
marked). 
4.  Severe depression on subjective or objective grounds (eg. profound loss of interest or 
pleasure, preoccupation with ideas of guilt or worthlessness). 
 
8. O ther mental and behavioural problems 
Rate only the most severe clinical problem not considered at Scales 6 and 7 as follows: 
specify the type of problem by entering the appropriate letter: A phobic: B anxiety; C 
obsessive-compulsive; D stress; E  dissociative; F  somatoform; G eating; H  sleep; I sexual; J 
other, specify. 
0. No evidence of any of these problems during period rated. 
1.  Minor non-clinical problems. 
2.  A problem is clinically present, but at a mild level, for example the problem is 
intermittent, the consumer maintains a degree of control or is not unduly distressed. 
3.  Moderately severe clinical problem, for example, more frequent, more distressing or more 
marked symptoms. 
4.  Severe persistent problems that dominates or seriously affects most activities. 
 
9. Problems with relationships 
Problems associated with social relationships, identified by the consumer or apparent to 
carers or others. Rate the consumer's most severe problem associated with active or passive 
withdrawal from, or tendency to dominate, social relationships or non-supportive, destructive 
or self-damaging relationships. 
0. No significant problems during the period. 
1.  Minor non-clinical problems. 
2.  Definite problems in making, sustaining or adapting to supportive relationships (eg. 
because of controlling manner, or arising out of difficult, exploitative or abusive 
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relationships), definite but mild difficulties reported by consumer or evident to carers or 
others. 
3.  Persisting significant problems with relationships; moderately severe conflicts or 
problems identified within the relationship by the consumer or evident to carers or others. 
4.  Severe difficulties associated with social relationships (eg. isolation, withdrawal, conflict, 
abuse); major tensions and stresses (eg. threatening breaking down of relationship). 
 
10. Problems with activities of daily living 
Rate the overall level of functioning in activities of daily living (ADL): eg. problems with 
basic activities of self-care such as eating, washing, dressing, toilet; also complex skills such 
as budgeting, recreation and use of transport, etc. 
Include any lack of motivation for using self-help opportunities, since this contributes to a 
lower overall level of functioning.               
Do not include lack of opportunities for exercising intact abilities and skills, rated at Scales 
11 and Scale 12. 
0. No problems during period rated; good ability to function effectively in all basic activities 
(eg. continent - or able to manage incontinence appropriately, able to feed self and dress) 
and complex skills (eg. driving or able to make use of transport facilities, able to handle 
financial affairs appropriately).  
1.  Minor problems only without significantly adverse consequences, for example, untidy, 
mildly disorganised, some evidence to suggest minor difficulty with complex skills but 
still able to cope effectively. 
2.  Self-care and basic activities adequate (though some prompting may be required), but 
difficulty with more complex skills (eg. problem organising and making a drink or meal, 
deterioration in personal interest especially outside the home situation, problems with 
driving, transport or financial judgements). 
3.  Problems evident in one or more areas of self-care activities (eg. needs some supervision 
with dressing and eating, occasional urinary incontinence or continent only if toileted) as 
well as inability to perform several complex skills. 
4.  Severe disability or incapacity in all or nearly all areas of basic and complex skills (eg. 
full supervision required with dressing and eating, frequent urinary or faecal 
incontinence). 
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11. Problems with living conditions 
Rate the overall severity of problems with the quality of living conditions, accommodation 
and daily domestic routine, taking into account the consumer's preferences and degree of 
satisfaction with circumstances. 
Are the basic necessities met (heat, light, hygiene)?  If so, does the physical environment 
contribute to maximising independence and minimising risk, and provide a choice of 
opportunities to facilitate the use of existing skills and develop new ones? 
Do not rate the level of functional disability itself, rated at Scale 10. 
NB: Rate consumer's usual accommodation. If in acute ward, rate the home accommodation. 
If information not obtainable, rate 7. 
0. Accommodation and living conditions are acceptable; helpful in keeping any disability 
rated at Scale 10 to the lowest level possible and minimising any risk, and supportive of 
self-help; the consumer is satisfied with their accommodation. 
1.  Accommodation is reasonably acceptable with only minor or transient problems related 
primarily to the consumer's preferences rather than any significant problems or risks 
associated with their environment (eg. not ideal location, not preferred option, doesn't like 
food). 
2.  Basics are met but significant problems with one or more aspects of the accommodation 
or regime (eg. lack of proper adaptation to optimise function relating for instance to stairs, 
lifts or other problems of access); may be associated with risk to consumer (eg. injury) 
which would otherwise be reduced. 
3.  Distressing multiple problems with accommodation; eg. some basic necessities are absent 
(unsatisfactory or unreliable heating, lack of proper cooking facilities, inadequate 
sanitation); clear elements of risk to the consumer resulting from aspects of the physical 
environment. 
4.  Accommodation is unacceptable: eg. lack of basic necessities, insecure, or living 
conditions are otherwise intolerable, contributing adversely to the consumer's condition or 
placing them at high risk of injury or other adverse consequences. 
 
12. Problems with occupation and activities 
Rate the overall level of problems with quality of day-time environment. Is there help to cope 
with disabilities, and opportunities for maintaining or improving occupational and 
recreational skills and activities? Consider factors such as stigma, lack of qualified staff, lack 
of access to supportive facilities, eg. staffing and equipment of day centres, social clubs, etc. 
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Do not rate the level of functional disability itself, rated at Scale 10. 
NB: Rate the consumer's usual situation. If in acute ward, rate activities during period before 
admission.  If information not available, rate 7. 
0. Consumer's day-time environment is acceptable; helpful in keeping any disability rated at 
Scale 10 to the lowest level possible, and maximising autonomy.  
1.  Minor or temporary problems, eg. good facilities available but not always at appropriate 
times for the consumer. 
2.  Limited choice of activities; e.g. insufficient carer or professional support, useful day 
setting available but for very limited hours. 
3.  Marked deficiency in skilled services and support available to help optimise activity level 
and autonomy, little opportunity to use skills or to develop new ones; unskilled care 
difficult to access. 
4.  Lack of any effective opportunity for daytime activities makes the consumer's problems 
worse or consumer refuses services offered which might improve their situation. 
 
Important variations in rating guidelines 
  Core  rules   
Scale   Rate  the  worst  
manifestation 
Rate  over  the  past  two  weeks  
Scales 1-8  Always  Always  
Scales 9, 
10  
Based on usual or 
typical  
Always  
Scales 11, 
12  
Based on usual or 
typical  
May need to go back beyond two weeks to establish 
the usual situation  
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APPE NDI X H 
C O NSE N T F O R M 
 
Consent form for participants 
 
Getting better : Evaluating outcome measures for depression in older people in mental 
health services 
 
I, ............................................................................................... (name)  
have read the participant information sheet for this study and I understand it. 
 
I understand that I do not have to take part in this study, it is my choice. I can withdraw at 
any time. This will not affect my health care in anyway. I do not have to answer any 
???????????????????????????????? 
 
Taking part in the study involves completing two questionnaires about how I am feeling and 
coping. The two questionnaires are each only a single page long. 
I am willing to answer the questionnaires   YES  /  NO 
 
The questionnaire will only be added to my patient notes if I say that it is ok.  
I would like my completed questionnaires  
to be put in my patient notes      YES  /  NO 
 
I can also help by suggesting a person close to me that a researcher would contact. The 
researcher will invite them to complete the questionnaires about how they think I am feeling 
and coping. 
I am willing to suggest someone, and for the 
researcher to invite them to take part     YES  /  NO 
 
The researchers will offer the same questionnaires when I am about to be discharged from 
Ward K2, to see how things have changed. I can decide then whether I want to complete 
them and whether it is ok for researchers to contact someone close to me again. 
I would like to be sent a summary of the results  
in mid 2010        YES  /  NO 
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I understand that my answers in the study are confidential and that no materials that 
might identify me will be used in any reports on this study. 
 
Before signing this form, I have had the opportunity to discuss the study with one of the 
researchers and to ask any questions about this study. I know that I am welcome to have 
whanau or family support or a friend to help me ask questions and understand the study. I 
have had enough time to consider my decision to take part. 
 
 
 
I  ................................................................................... (full name) hereby agree to participate 
in this study. 
 
SIGNATURE: ......................................................  
 
DATE: ................................. 
 
 
 
 
 
 
 
??? ????????????????????????????????????????????????????????
explained the nature and purpose of this study to the participant whose name is printed above. 
 
RESEARCHER SIGNATURE:  
 
............................................................... 
 
DATE: ........................................................ 
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Consent form for informants 
 
Getting better : Evaluating outcome measures for depression in older people in mental 
health services 
 
I............................................................................................... (name)  
have read the participant information sheet for this study and I understand it. 
 
I understand that I do not have to take part in this study, it is my choice. I can withdraw at 
any time. This will not affect my health care in anyway. I do not have to answer any 
???????????????????????????????? 
 
Taking part in the study involves completing two questionnaires about how 
______________is feeling and coping. The two questionnaires are each only a single page 
long. 
 
The researchers will offer the same questionnaires when ____________is  about to be 
discharged from Ward K2, to see how things have changed. I can decide then whether I want 
to complete them. 
 
I would like to be sent a summary of the results  
in mid 2010        YES  /  NO 
 
I understand that my answers in the study are confidential and that no materials that might 
identify me will be used in any reports on this study. 
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Before signing this form, I have had the opportunity to discuss the study with one of the 
researchers and to ask any questions about this study. I know that I am welcome to have 
whanau or family support or a friend to help me ask questions and understand the study. I 
have had enough time to consider my decision to take part. 
 
I  ................................................................................... (full name) hereby agree to participate 
in this study. 
 
SIGNATURE: ......................................................  
 
DATE: ................................. 
 
??? ????????????????????????????????????????????????????
explained the nature and purpose of this study to the participant whose name is printed above. 
 
RESEARCHER SIGNATURE:............................................................... 
 
DATE: ........................................................ 
A signed copy of this document must be given to the informant. 
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APPE NDI X I 
??????????????????????????????????? 
Getting better : Evaluating outcome measures for depression in older people in mental 
health services 
Information for friends and family 
 
Principal researchers:   
Katarzyna (Kasia) Madrzejewska, Masters Student 
Matthew Croucher, Consultant Psychiatrist 
Susan Gee, Research Associate 
 
Psychiatry Service for the Elderly 
Princess Margaret Hospital 
PO BOX 731 
Christchurch 8022 
Tel: 03 337 8894 
 
 
 
You are invited to take part in our study looking at how we can best measure how 
people are feeling and coping, and whether they are getting better . 
 
You do not have to take part in this study, it is your choice. 
 
Please read these pages to find out more about the study before you make up your mind. 
 
Please take your time to think about whether you would like to take part.  You may like to 
talk it over with someone close to you. Feel free to ask any questions. 
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About the study 
This study looks at what is the best outcome measure to use. It also looks at whether it is 
useful to ask someone close to a patient to complete the questionnaires for them. This is a 
very important question because sometimes patients may be unable to complete a 
questionnaire.   
We would like to compare the answers given by people who are admitted to Ward K2 to the 
outcome questionnaires with the answers given by someone close to them. 
______________________has completed these questionnaires, and they suggested you as a 
person close to them. 
 
? The study is open to anyone suggested by a person admitted to Ward K2 who is able to 
complete the questionnaires.  
? The study will involve up to 120 people. We will be conducting the study from April 
2009 to June 2010. 
 
If you would like to take part in the study, you will complete two questionnaires.  
? The questionnaires will ask how ____________________is feeling and how they are 
coping with their usual life activities.  
? The two questionnaires are each only a single page long. 
? Just let us know if you would like the support of the Maori Mental Health Worker, or 
would like the help of an interpreter. 
? We will offer the same questionnaires to you again when ____________________ is 
about to be discharged to see how things have changed. 
 
This research will be conducted by Kasia Madrzejewska. She is a psychology student 
completing her masters degree at the university of Canterbury. 
? Kasia will contact you to see if you interested in taking part. 
?  She will check what would be most convenient for you ? to fill out the questionnaires 
yourself, to answer the questions over the phone, or to meet with her when you are 
visiting Ward K2. 
? She will give you the same two questionnaires as ___________ completed, to see how 
you think they are feeling and coping. 
? We will offer the same questionnaires again when they are about to be discharged to see 
how things have changed.  
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Benefits and risks of the study 
We hope that this research will help us to improve how we measure whether people are 
feeling better. 
The people taking part on Ward K2 will have the opportunity to have the questionnaires 
placed in their patient notes if they would like. Staff could then use the information to better 
understand their progress and address their needs. 
We do not foresee any risks involved in the study.  
 
Participation 
You do not have to take part in this study. It is your choice. 
? You can change your mind at any time and stop the questionnaire, or withdraw your 
comments. Just let one of the research team know. You do not have to give a reason. 
? You do not have to answer any question that you do not want to. 
? Declining to take part in the study or withdrawing from the study will not affect health 
care on the ward now or in the future. 
 
Confidentiality 
We want you to feel comfortable telling us what you really think. 
? No material which could personally identify you or the people on Ward K2 will be used 
in any reports on this study. 
? If you did say in the questionnaires that the person felt like harming themself, we would 
always let their treatment staff know.  
? ???????????????????????????????????????????????????????????????????????????????????????????
for 10 years. This is in case we need to go back to the questionnaires to check anything. 
 
Results 
The information from this study will be used to help us to decide what questions we should 
routinely ask.  We will also share the results in written papers and in talks so that it can help 
staff in other services. 
We would be happy to send you a summary of the results when the study finishes mid 2010.  
 
 
 
     
  
117 
General 
If you have any questions please feel free to contact Kasia on 376 4510. Or you could contact 
the Research Associate. Her name is Susan Gee. You can call her on 337 8894. 
This study has received ethical approval from the Upper South B Regional Ethics Committee. 
If you have any queries or concerns regarding your rights as a participant in the study you 
may wish to contact a Health and Disability advocate. Their telephone number is (03) 377 
7501 
 
Compensation: 
In the unlikely event of a physical injury as a result of your participation in this study, you 
may be covered by ACC under the Injury Prevention, Rehabilitation and Compensation Act. 
ACC cover is not automatic and your case will need to be assessed by ACC according to the 
provisions of the 2002 Injury Prevention Rehabilitation and Compensation Act. If your claim 
is accepted by ACC, you still might not get any compensation. This depends on a number of 
factors such as whether you are an earner or non-earner. ACC usually provides only partial 
reimbursement of costs and expenses and there may be no lump sum compensation payable. 
There is no cover for mental injury unless it is a result of physical injury. If you have ACC 
cover, generally this will affect your right to sue the investigators.  
If you have any questions about ACC, contact your nearest ACC office or the investigator. 
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APPE NDI X J 
H U M A N E T H I CS C O M M I T T E E APPR O V A L 
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